0001753926-23-001432.txt : 20231107 0001753926-23-001432.hdr.sgml : 20231107 20231107163503 ACCESSION NUMBER: 0001753926-23-001432 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231107 DATE AS OF CHANGE: 20231107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTER PARFUMS INC CENTRAL INDEX KEY: 0000822663 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 133275609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-16469 FILM NUMBER: 231384481 BUSINESS ADDRESS: STREET 1: 551 FIFTH AVE STREET 2: STE 1500 CITY: NEW YORK STATE: NY ZIP: 10176 BUSINESS PHONE: 2129832640 MAIL ADDRESS: STREET 1: 551 FIFTH AVENUE STREET 2: STE 1500 CITY: NEW YORK STATE: NY ZIP: 10176 FORMER COMPANY: FORMER CONFORMED NAME: JEAN PHILIPPE FRAGRANCES INC DATE OF NAME CHANGE: 19920703 10-Q 1 g083828_10q.htm 10-Q
false 2023 Q3 --12-31 0000822663 NY P7Y P50Y P10Y 120000000 80000000 P4Y P10Y P1Y P5Y4M24D 4000000 P4Y P5Y 86613 234674 86613 234674 P2Y1M24D P0Y4M2D 0000822663 2023-01-01 2023-09-30 0000822663 2023-11-07 0000822663 2023-09-30 0000822663 2022-12-31 0000822663 2023-07-01 2023-09-30 0000822663 2022-07-01 2022-09-30 0000822663 2022-01-01 2022-09-30 0000822663 us-gaap:CommonStockMember 2022-12-31 0000822663 us-gaap:CommonStockMember 2021-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000822663 us-gaap:RetainedEarningsMember 2022-12-31 0000822663 us-gaap:RetainedEarningsMember 2021-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000822663 us-gaap:TreasuryStockCommonMember 2022-12-31 0000822663 us-gaap:TreasuryStockCommonMember 2021-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2021-12-31 0000822663 2021-12-31 0000822663 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0000822663 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0000822663 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0000822663 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0000822663 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-09-30 0000822663 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-09-30 0000822663 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-09-30 0000822663 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-09-30 0000822663 us-gaap:CommonStockMember 2023-09-30 0000822663 us-gaap:CommonStockMember 2022-09-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000822663 us-gaap:RetainedEarningsMember 2023-09-30 0000822663 us-gaap:RetainedEarningsMember 2022-09-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000822663 us-gaap:TreasuryStockCommonMember 2023-09-30 0000822663 us-gaap:TreasuryStockCommonMember 2022-09-30 0000822663 us-gaap:NoncontrollingInterestMember 2023-09-30 0000822663 us-gaap:NoncontrollingInterestMember 2022-09-30 0000822663 2022-09-30 0000822663 ipar:RobertoCavalliMember 2023-01-01 2023-09-30 0000822663 ipar:LacosteMember 2023-01-01 2023-09-30 0000822663 ipar:DonnaKaranAndDKNYMember 2023-01-01 2023-09-30 0000822663 ipar:RochasFashionMember 2023-01-01 2023-09-30 0000822663 ipar:InterparfumsSAMember 2021-04-30 0000822663 us-gaap:LandMember 2023-01-01 2023-09-30 0000822663 us-gaap:BuildingMember 2023-01-01 2023-09-30 0000822663 srt:MinimumMember 2023-09-30 0000822663 srt:MaximumMember 2023-09-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000822663 currency:EUR 2022-12-31 0000822663 currency:EUR 2021-04-30 0000822663 2021-04-30 0000822663 currency:EUR us-gaap:InterestRateSwapMember 2021-04-30 0000822663 us-gaap:ForeignExchangeContractMember 2023-09-30 0000822663 currency:GBP us-gaap:ForeignExchangeContractMember 2023-09-30 0000822663 us-gaap:ForeignExchangeContractMember 2023-01-01 2023-09-30 0000822663 us-gaap:StockOptionMember srt:MinimumMember 2023-01-01 2023-09-30 0000822663 us-gaap:StockOptionMember srt:MaximumMember 2023-01-01 2023-09-30 0000822663 us-gaap:StockOptionMember 2023-01-01 2023-09-30 0000822663 us-gaap:StockOptionMember 2022-01-01 2022-09-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2018-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:OfficersAndManagersMember 2018-12-31 0000822663 2022-06-01 2022-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2023-01-01 2023-09-30 0000822663 ipar:InterparfumsSASubsidiaryMember 2023-01-01 2023-09-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2023-09-30 0000822663 country:US 2023-07-01 2023-09-30 0000822663 country:US 2022-07-01 2022-09-30 0000822663 country:US 2023-01-01 2023-09-30 0000822663 country:US 2022-01-01 2022-09-30 0000822663 srt:EuropeMember 2023-07-01 2023-09-30 0000822663 srt:EuropeMember 2022-07-01 2022-09-30 0000822663 srt:EuropeMember 2023-01-01 2023-09-30 0000822663 srt:EuropeMember 2022-01-01 2022-09-30 0000822663 ipar:EliminationsMember 2023-07-01 2023-09-30 0000822663 ipar:EliminationsMember 2022-07-01 2022-09-30 0000822663 ipar:EliminationsMember 2023-01-01 2023-09-30 0000822663 ipar:EliminationsMember 2022-01-01 2022-09-30 0000822663 country:US 2023-09-30 0000822663 country:US 2022-12-31 0000822663 srt:EuropeMember 2023-09-30 0000822663 srt:EuropeMember 2022-12-31 0000822663 ipar:EliminationsMember 2023-09-30 0000822663 ipar:EliminationsMember 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:EUR iso4217:GBP iso4217:JPY

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(MARK ONE)

 

Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2023.

 

OR

 

Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ___________to ________.

 

Commission File No. 0-16469

 

INTER PARFUMS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   13-3275609
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

551 Fifth AvenueNew YorkNew York     10176
(Address of Principal Executive Offices)          (Zip Code)

 

(212) 983-2640
(Registrants telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
 Common Stock, $.001 par value per share   IPAR    The Nasdaq Stock Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act).

 

Large accelerated filer Accelerated filer ☐
Non-accelerated filer ☐ (Do not check if a smaller reporting company) Smaller reporting company
  Emerging Growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

At November 7, 2023, there were 31,980,805 shares of common stock, par value $.001 per share, outstanding.

 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

  

INDEX

 

  Page Number
   
Part I. Financial Information 1
       
  Item 1. Financial Statements  
       
      Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022 2
       
      Consolidated Statements of Income for the Three and Nine Months Ended September 30, 2023 and September 30, 2022 3
       
      Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2023 and September 30, 2022 4
       
      Consolidated Statements of Changes in Equity for the Nine Months Ended September 30, 2023 and September 30, 2022 5
       
      Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2023 and September 30, 2022 6
       
      Notes to Consolidated Financial Statements 7
       
  Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
       
  Item 3. Quantitative and Qualitative Disclosures About Market Risk 26
       
  Item 4. Controls and Procedures 27
       
Part II. Other Information 27
       
  Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities 27
       
  Item 6. Exhibits 28
       
Signatures 29

 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Part I. Financial Information

 

Item 1.Financial Statements

 

In our opinion, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows for the interim periods presented. We have condensed such financial statements in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). Therefore, such financial statements do not include all disclosures required by accounting principles generally accepted in the United States of America. In preparing these consolidated financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued by filing with the SEC. These financial statements should be read in conjunction with our audited financial statements for the year ended December 31, 2022, included in our annual report filed on Form 10-K.

 

The results of operations for the nine months ended September 30, 2023, are not necessarily indicative of the results to be expected for the entire fiscal year.

 

Page 1

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS

(In thousands except share and per share data)

(Unaudited)

 

           
ASSETS
   September 30,
2023
   December 31,
2022
 
Current assets:          
Cash and cash equivalents  $79,764   $104,713 
Short-term investments   103,745    150,833 
Accounts receivable, net   288,085    197,584 
Inventories   364,270    289,984 
Receivables, other   13,645    28,803 
Other current assets   26,847    15,650 
Income taxes receivable   498    157 
Total current assets   876,854    787,724 
Property, equipment and leasehold improvements, net   163,002    166,722 
Right-of-use assets, net   29,359    27,964 
Trademarks, licenses and other intangible assets, net   286,697    290,853 
Deferred tax assets   16,063    11,159 
Other assets   22,422    24,120 
Total assets  $1,394,397   $1,308,542 
           
LIABILITIES AND EQUITY 
Current liabilities:          
Loans payable - banks  $4,501   $ 
Current portion of long-term debt   41,768    28,547 
Current portion of lease liabilities   5,687    5,296 
Accounts payable – trade   87,161    88,388 
Accrued expenses   200,065    213,621 
Income taxes payable   23,913    8,715 
Total current liabilities   363,095    344,567 
           
Long–term debt, less current portion   128,983    151,494 
Lease liabilities, less current portion   25,452    24,335 
           
Equity:          
Inter Parfums, Inc. shareholders’ equity:          
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued        

Common stock, $.001 par; authorized 100,000,000 shares; outstanding 31,980,805 and 31,967,300 shares at September 30, 2023 and December 31, 2022, respectively

   32    32 
Additional paid-in capital   95,752    90,186 
Retained earnings   703,091    620,095 
Accumulated other comprehensive loss   (59,802)   (56,056)
Treasury stock, at cost, 9,949,865 and 9,864,805 shares at September 30, 2023 and December 31, 2022, respectively   (48,764)   (37,475)
Total Inter Parfums, Inc. shareholders’ equity   690,309    616,782 
Noncontrolling interest   186,558    171,364 
Total equity   876,867    788,146 
Total liabilities and equity  $1,394,397   $1,308,542 

 

See notes to consolidated financial statements.

 

Page 2

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

  

CONSOLIDATED STATEMENTS OF INCOME

(In thousands except per share data)

(Unaudited)

 

                     
   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2023   2022   2023   2022 
                 
Net sales  $367,969   $280,462   $988,936   $775,865 
                     
Cost of sales   132,962    98,562    362,568    281,525 
                     
Gross margin   235,007    181,900    626,368    494,340 
                     
Selling, general and administrative expenses   147,805    117,424    393,866    323,249 
                     
Income from operations   87,202    64,476    232,502    171,091 
                     
Other expenses (income):                    
Interest expense   2,397    682    7,030    2,589 
(Gain) loss on foreign currency   (669)   273    (656)   (2,245)
Interest and investment income   (1,062)   (3,343)   (8,421)   (2,341)
Other (income) expense   (77)   346    (125)   (98)
                     
Nonoperating expense (income)   589    (2,042)   (2,172)   (2,095)
                     
Income before income taxes   86,613    66,518    234,674    173,186 
                     
Income taxes   20,493    13,221    55,128    39,078 
                     
Net income   66,120    53,297    179,546    134,108 
                     
Less:  Net income attributable to the noncontrolling interest   12,906    11,874    37,312    29,769 
                     
Net income attributable to Inter Parfums, Inc.
  $53,214   $41,423   $142,234   $104,339 
                     
Earnings per share:                    
                     
Net income attributable to Inter Parfums, Inc. common shareholders:                    
   Basic  $1.66   $1.30   $4.44   $3.28 
   Diluted  $1.66   $1.30   $4.42   $3.26 
                     
Weighted average number of shares outstanding:                    
   Basic   31,976    31,860    32,000    31,848 
   Diluted   32,124    31,968    32,149    31,977 
                     
Dividends declared per share  $0.625   $0.50   $1.875   $1.50 

 

See notes to consolidated financial statements.

 

Page 3

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

  

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)

 

                     
   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2023   2022   2023   2022 
Comprehensive income:                    
                     
Net income  $66,120   $53,297   $179,546   $134,108 
                     
Other comprehensive income:                    
                     
Net derivative instrument (loss) gain, net of tax   (363)   1,315    (4,606)   (173)
                     
Transfer from OCI into earnings
           1,709    992 
                     
Translation adjustments, net of tax   (15,692)   (32,944)   (2,657)   (79,015)
                     
Comprehensive income   50,065    21,668    173,992    55,912 
                     
Comprehensive income attributable to the noncontrolling interests:                    
                     
    Net income   12,906    11,874    37,312    29,769 
                     
    Other comprehensive income:                    
                     
Net derivative instrument (loss) gain, net of tax
   (100)   362    (327)   (49)
                     
Translation adjustments, net of tax   (4,892)   (10,012)   (1,481)   (24,174)
                     
Comprehensive income attributable to the noncontrolling interests   7,914    2,224    35,504    5,546 
                     
Comprehensive income attributable to Inter Parfums, Inc.  $42,151   $19,444   $138,488   $50,366 

 

See notes to consolidated financial statements.

 

Page 4

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

  

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(In thousands)

(Unaudited)

 

               
   Nine months ended
September 30,
 
   2023   2022 
         
Common stock, beginning and end of period  $32   $32 
         
         
Additional paid-in capital, beginning of period   90,186    87,132 
Shares issued upon exercise of stock options   5,523    1,816 
Share-based compensation   935    1,017 
Purchase of subsidiary shares   (892)   (4,305)
Additional paid-in capital, end of period   95,752    85,660 
           
Retained earnings, beginning of period   620,095    560,663 
Net income   142,234    104,339 
Dividends   (60,058)   (47,782)
Share-based compensation   820    1,664 
Retained earnings, end of period   703,091    618,884 
           
Accumulated other comprehensive loss, beginning of   period   (56,056)   (38,432)
Foreign currency translation adjustment, net of tax   (1,176)   (54,841)
Transfer from other comprehensive income into earnings   1,709    992 
Net derivative instrument loss, net of tax   (4,279)   (124)
Accumulated other comprehensive loss, end of period   (59,802)   (92,405)
           
Treasury stock, beginning of period   (37,475)   (37,475)
Shares repurchased   (11,289)    
Treasury stock, end of period   (48,764)   (37,475)
           
Noncontrolling interest, beginning of period   171,364    166,412 
Net income   37,312    29,769 
Foreign currency translation adjustment, net of tax   (1,481)   (24,174)
Net derivative instrument loss, net of tax   (327)   (49)
Share-based compensation (adjustment)   133    (353)
Purchase of subsidiary shares   (142)   (152)
Transfer of subsidiary shares purchased       55 
Dividends   (20,301)   (16,056)
Noncontrolling interest, end of period   697,321    155,452 
         
         
Total equity  $876,867   $730,148 

 

See notes to consolidated financial statements.

 

Page 5

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

  

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

               
   Nine months ended
September 30,
 
   2023   2022 
Cash flows from operating activities:          
Net income  $179,546   $134,108 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:          
Depreciation and amortization   12,781    10,936 
Provision for doubtful accounts   (560)   2,004 
Noncash stock compensation   1,887    2,353 
Share of income of equity investment   (125)   (98)
Noncash lease expense   4,163    4,074 
Deferred tax benefit   (5,075)   (3,658)
Change in fair value of derivatives   740    1,348 
Changes in:          
Accounts receivable   (96,076)   (89,605)
Inventories   (76,786)   (109,377)
Other assets   3,077    2,615 
Operating lease liabilities   (4,044)   (3,887)
Accounts payable and accrued expenses   (10,919)   26,406 
Income taxes, net   15,669    14,606 
           
Net cash provided by (used in) operating activities   24,278    (8,175)
           
Cash flows from investing activities:          
Purchases of short-term investments   (145,427)   (2,862)
Proceeds from sale of short-term investments   192,568    5,346 
Purchases of property, equipment and leasehold improvements   (4,574)   (32,615)
Payment for intangible assets acquired   (2,063)   (3,757)
           
   Net cash provided by (used in) investing activities   40,504    (33,888)
           
Cash flows from financing activities:          
Proceeds from loans payable, bank   4,501     
Proceeds from issuance of long-term debt   13,680     
Repayment of long-term debt   (22,527)   (14,210)
Proceeds from exercise of options   5,523    1,816 
Purchase of subsidiary shares from noncontrolling interest       (4,402)
Dividends paid   (60,058)   (47,782)
Dividends paid to noncontrolling interest   (20,301)   (16,056)
Purchase of treasury stock   (11,289)    
           
   Net cash used in financing activities   (90,471)   (80,634)
           
Effect of exchange rate changes on cash   740    (4,413)
           
Net decrease in cash and cash equivalents   (24,949)   (127,110)
           
Cash and cash equivalents - beginning of period   104,713    168,387 
           
Cash and cash equivalents - end of period  $79,764   $41,227 
           
Supplemental disclosure of cash flow information:          
Cash paid for:          
   Interest  $4,659   $2,091 
   Income taxes   44,693    27,718 

 

See notes to consolidated financial statements.

 

Page 6

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

1.Significant Accounting Policies:

 

The accounting policies we follow are set forth in the notes to our consolidated financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, 2022.

 

2.Impact of COVID-19 Pandemic:

 

Our business has continued to significantly improve throughout 2022 and the first three quarters of 2023 after the disastrous effects of the COVID-19 Pandemic starting in early 2020, as retail stores reopened, and consumers increased online purchasing. While the COVID-19 Pandemic had significantly restricted international travel, the travel retail business has picked up. Lastly, we experienced significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions came at a time when demand for our product lines has never been stronger or more sustained. We have addressed this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. The supply chain bottlenecks have been improving and while lead times remain longer than pre-COVID, we do not expect significant disruptions going forward. 

 

3.Recent Agreements:

 

Roberto Cavalli

 

In July 2023, we closed a transaction agreement with Roberto Cavalli, whereby an exclusive and worldwide license was granted for the production and distribution of Roberto Cavalli brand perfumes and fragrance related products. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license became effective in July 2023 and will last for 6.5 years.

 

Lacoste

 

In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.

 

Dunhill

 

The Dunhill fragrance license has expired on September 30, 2023 and will not be renewed. The Company has now entered the twelve month sell-off period during which it will maintain the right to sell-off remaining Dunhill fragrance inventory, which is customary in the fragrance industry. All usable components have been converted to finished goods, and any remaining components will be destroyed. 

 

Donna Karan and DKNY

 

In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we have gained several well-established and valuable fragrance franchises, most notably Donna Karan Cashmere Mist and DKNY Be Delicious, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock to the licensor valued at $5.0 million. The exclusive license became effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024. 

 

Page 7

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

Rochas Fashion

 

Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.

 

Land and Building Acquisition - Headquarters in Paris

 

In April 2021, Interparfums SA, our 72% owned French Subsidiary, completed the acquisition of its headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.

 

The purchase price included the complete renovation of the site. As of September 30, 2023, $148.1 million of the purchase price, including approximately $3 million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet. The purchase price has been allocated approximately $60.7 million to land and $87.4 million to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of 7 to 50 years. The Company has elected to depreciate the building cost based on the useful lives of its components. Approximately $1.2 million of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of September 30, 2023.

 

The acquisition was financed by a 10-year €120 million (approximately $127.1 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately €80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. The swap effectively exchanges the variable interest rate to a fixed rate of approximately 1.1%.

 

4.Recent Accounting Pronouncements:

 

There are no recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.

 

Page 8

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

5.Inventories:

 

Inventories consist of the following:

 

(In thousands) 

September 30,

2023

  

December 31,

2022

 
Raw materials and component parts  $151,344   $146,772 
Finished goods   212,926    143,212 
           
Inventories  $364,270   $289,984 

 

 

6.Fair Value Measurement:

 

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

 

                         
       Fair Value Measurements at September 30, 2023 
       Quoted Prices in   Significant Other   Significant 
       Active Markets for   Observable   Unobservable 
       Identical Assets   Inputs   Inputs 
   Total   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Short-term investments  $103,745   $10,177   $92,776   $792 
Interest rate swaps   6,274        6,274     
                     
Total asset  $110,019   $10,177   $99,050   $792 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting  $791   $   $791   $ 
Foreign currency forward exchange contracts accounted for using hedge accounting   489        489      
                     
 Total liabilities  $1,280   $   $1,280   $ 

 

Page 9

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

                       
       Fair Value Measurements at December 31, 2022 
       Quoted Prices in   Significant Other   Significant 
       Active Markets for   Observable   Unobservable 
       Identical Assets   Inputs   Inputs 
   Total   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Short-term investments  $150,833   $19,861   $130,174   $798 
Interest rate swaps   6,758        6,758     
Foreign currency forward exchange contracts accounted for using hedge accounting   1,189        1,189     
                     
Total asset  $158,780   $19,861   $138,121   $798 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting   68        68     
                     
Total liabilities  $68   $   $68   $ 

 

The carrying amount of cash and cash equivalents including money market funds, short-term investments, accounts receivable, other receivables, cash held in escrow, accounts payable and accrued expenses approximate fair value due to the short terms to maturity of these instruments.

 

The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.

 

Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net present value of the swaps using third party quotes from financial institutions.

 

7.Derivative Financial Instruments:

 

The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings. 

 

Page 10

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a €50 million (approximately $53 million) 4-year term loan with a variable interest rate. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. This swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.

 

In connection with the April 2021 acquisition of the office building complex in Paris, €120 million (approximately $127.1 million) of the purchase price was financed through a 10-year term loan. The Company entered into interest rate swap contracts related to €80 million of the loan, effectively exchanging the variable interest rate to a fixed rate of approximately 1.1%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

 

Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial for the three and nine months ended September 30, 2023 and 2022.

 

All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swaps is included in other assets on the accompanying balance sheets. The valuation of foreign currency forward exchange contracts at September 30, 2023 resulted in a net asset and is included in other current assets on the accompanying balance sheet.

 

At September 30, 2023, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $58.0 million and GB £2.0 million which all have maturities of less than one year.

 

8.Leases:

 

The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.

 

In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.

 

Page 11

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

As of September 30, 2023, the weighted average remaining lease term was 5.4 years and the weighted average discount rate used to determine the operating lease liability was 3.0%. Rental expense related to operating leases was $1.5 million and $4.5 million for the three and nine months ended September 30, 2023, respectively, as compared to $1.2 million and $4.3 million for the corresponding periods of the prior year. Operating lease payments included in operating cash flows totaled $4.0 million and $3.9 million for the nine months ended September 30, 2023 and 2022, respectively, and noncash additions to operating lease assets totaled $5.7 million and $0.5 million for the nine months ended September 30, 2023 and 2022, respectively.

 

9.Share-Based Payments:

 

The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to five-year period. The fair value of shares vested during the nine months ended September 30, 2023 and 2022 aggregated $0.10 million and $0.11 million, respectively. Compensation cost, net of forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options.

 

The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023:

 

  

Number of

Shares

  

Weighted

Average

Grant-Date

Fair Value

 
Nonvested options – beginning of period   168,730   $16.31 
Nonvested options granted        
Nonvested options vested or forfeited   (27,625)  $13.91 
Nonvested options – end of period   141,105   $16.78 

 

Share-based payment expense decreased income before income taxes by $0.62 million and $1.89 million for the three and nine months ended September 30, 2023, respectively, as compared to $0.47 million and $2.35 million for the corresponding periods of the prior year. Share-based payment expense decreased income attributable to Inter Parfums, Inc. by $0.41 million and $1.27 million for the three and nine months ended September 30, 2023, respectively, as compared to $0.34 million and $1.52 million for the corresponding periods of the prior year.

 

The following table summarizes stock option information as of September 30, 2023:

 

   Shares  

Weighted

Average

Exercise Price

 
         
Outstanding at January 1, 2023   441,580   $67.30 
Options forfeited   (20,025)   72.22 
Options exercised   (98,565)   56.03 
           
Outstanding at September 30, 2023   322,990   $70.43 
          
Options exercisable   181,885   $61.44 
Options available for future grants   579,000      

 

Page 12

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

As of September 30, 2023, the weighted average remaining contractual life of options outstanding is 2.15 years (0.34 years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $20.64 million and $13.26 million, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $1.7 million.

 

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows:

 

(In thousands)  September 30, 
2023
   September 30, 
2022
 
         
Cash proceeds from stock options exercised  $5,523   $1,816 
Tax benefits   900    320 
Intrinsic value of stock options exercised   6,135    2,105 

 

There were no options granted during the nine months ended September 30, 2023 and September 30, 2022.

 

Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would increase as the earnings of the Company and its stock price continues to increase.

 

In December 2018, Interparfums SA approved a plan to grant an aggregate of 26,600 shares of its stock to employees with no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate performance conditions. The corporate performance conditions were met and therefore in June 2022, 211,955 shares, adjusted for stock splits, were distributed. The aggregate cost of the grant of approximately $4.8 million was recognized as compensation cost on a straight-line basis over the requisite three-year service period.

 

In March 2022, Interparfums SA approved an additional plan to grant an aggregate of 88,400 shares to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.

 

The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the NYSE Euronext on the date of grant. The estimated number of shares to be distributed of 92,998 has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $4.2 million will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.

 

Similar to the December 2018 plan, in order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. As of September 30, 2023 the Company acquired 87,609 shares at an aggregate cost of $4.1 million.

 

All share purchases and issuances have been classified as equity transactions on the accompanying balance sheet.

 

Page 13

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

10.Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

 

Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.

 

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

                             
   Three months ended   Nine months ended 
(In thousands)  September 30,   September 30, 
   2023   2022   2023   2022 
Numerator:                
Net income attributable to Inter Parfums, Inc.  $53,214   $41,423   $142,234   $104,339 
Denominator:                    
Weighted average shares   31,976    31,860    32,000    31,848 
Effect of dilutive securities:                    
Stock options   148    108    149    129 
Denominator for diluted earnings per share   32,124    31,968    32,149    31,977 
                     
Earnings per share:                    
Net income attributable to Inter
Parfums, Inc. common shareholders:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic  $1.66   $1.30   $4.44   $3.28 
Diluted   1.66    1.30    4.42    3.26 

 

There were no antidilutive potential common shares outstanding for the three and nine months ended September 30, 2023. Not included in the above computations are the effect of antidilutive potential common shares which consist of outstanding options to purchase 0.15 million shares of common stock for both the three and nine months ended September 30, 2022, respectively.

 

Page 14

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

11.Segment and Geographic Areas:

 

The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European operations and United States operations primarily represent the sale of prestige brand name fragrances.

 

Information on our operations by geographical areas is as follows:

 

(In thousands)  Three months ended
September 30,
   Nine months ended
September 30,
 
   2023   2022   2023   2022 
Net sales:                    
United States  $134,469   $82,183   $327,359   $229,129 
Europe   233,500    198,318    661,577    546,787 
Eliminations       (39)       (51)
                     
   $367,969   $280,462   $988,936   $775,865 
                     
Net income attributable to Inter Parfums, Inc.:                    
United States  $20,157   $10,881   $46,067   $27,386 
Europe   33,057    30,542    96,167    76,953 
                     
   $53,214   $41,423   $142,234   $104,339 
                     
             September 30,   December 31, 
             2023   2022 
Total Assets:                    
United States            $340,375   $278,090 
Europe             1,083,843    1,052,004 
Eliminations             (29,821)   (21,552)
             $1,394,397   $1,308,542 

 

 

Page 15

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Item 2:MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward Looking Information

 

Statements in this report which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved. In some cases, you can identify forward-looking statements by forward-looking words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will” and “would” or similar words. You should not rely on forward-looking statements because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and “Risk Factors” in Inter Parfums’ annual report on Form 10-K for the fiscal year ended December 31, 2022, and the reports Inter Parfums files from time to time with the Securities and Exchange Commission (“SEC”). Inter Parfums does not intend to and undertakes no duty to update the information contained in this report.

 

Overview

 

We operate in the fragrance business, and manufacture, market and distribute a wide array of fragrances and fragrance related products. We manage our business in two segments, European based operations and United States based operations. Certain prestige fragrance products are produced and marketed by our European operations through our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 28% of Interparfums SA shares trade on the NYSE Euronext.

 

We produce and distribute our European based fragrance products primarily under license agreements with brand owners, and European based fragrance product sales represented approximately 67% and 70% of net sales for the nine months ended September 30, 2023 and 2022, respectively. We have built a portfolio of prestige brands, which include Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, S.T. Dupont, Rochas and Van Cleef & Arpels, whose products are distributed in over 120 countries around the world. In addition, our exclusive and worldwide license for the production and distribution of Lacoste brand perfumes and cosmetics becomes effective in January 2024.

 

Through our United States operations, we also market fragrance and fragrance related products. United States operations represented 33% and 30% of net sales for the nine months ended September 30, 2023 and 2022, respectively. These fragrance products are sold primarily pursuant to license or other agreements with the owners of the Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta, Roberto Cavalli and Ungaro brands.

 

Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Coach, Jimmy Choo, GUESS, Donna Karan/DKNY and Ferragamo brand names. This diversified portfolio of top brands represented 74% of total sales for the first 9 months of 2023 up from 69% in 2022.

 

Page 16

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

As a percentage of net sales, product sales for the Company’s largest brands were as follows:

 

  

Nine Months Ended  

September 30,

 
   2023   2022 
         
Montblanc   18%   19%
Jimmy Choo   17%   18%
Coach   15%   15%
GUESS   11%   11%
Donna Karan/DKNY   7%   1%
Ferragamo   5%   5%

 

Quarterly sales fluctuations are influenced by the timing of new product launches as well as the third and fourth quarter holiday season. In certain markets where we sell directly to retailers, seasonality is more evident. We primarily sell directly to retailers in France, the United States, and Italy.

 

We grow our business in two distinct ways. First, we grow by adding new brands to our portfolio, through new licenses, other arrangements or out-right acquisitions of brands. Second, we grow through the introduction of new products and by supporting new and established products through advertising, merchandising and sampling as well as phasing out underperforming products so we can devote greater resources to those products with greater potential. The economics of developing, producing, launching and supporting products influence our sales and operating performance each year. Our introduction of new products may have some cannibalizing effect on sales of existing products, which we take into account in our business planning.

 

Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are received at one of our distribution centers and then, based upon production needs, the components are sent to one of several third-party fillers, which manufacture the finished product for us and then deliver them to one of our distribution centers.

 

As with any global business, many aspects of our operations are subject to influences outside our control. We believe we have a strong brand portfolio with global reach and potential. As part of our strategy, we plan to continue to make investments behind fast-growing markets and channels to grow market share. 

 

Our reported net sales are impacted by changes in foreign currency exchange rates. A strong U.S. dollar has a negative impact on our net sales. However, earnings are positively affected by a strong dollar, because almost 50% of net sales of our European operations are denominated in U.S. dollars, while almost all costs of our European operations are incurred in euro. Conversely, a weak U.S. dollar has a favorable impact on our net sales while gross margins are negatively affected. We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments and primarily enter into foreign currency forward exchange contracts to reduce the effects of fluctuating foreign currency exchange rates.

 

Page 17

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Impact of COVID-19 Pandemic

 

Please see our discussion of the Impact of the COVID-19 Pandemic, which is incorporated by reference to note 2 to the Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q for the quarter ended September 30, 2023.

 

Recent Important Events

 

Please see our discussion of Recent Important Events, which is incorporated by reference to note 3 to the Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q for the quarter ended September 30, 2023.

 

Discussion of Critical Accounting Policies

 

Information regarding our critical accounting policies can be found in our 2022 Annual Report on Form 10-K filed with the SEC.

 

Results of Operations

 

Three and Nine Months Ended September 30, 2023 as Compared to the Three and Nine Months Ended September 30, 2022

 

Net Sales:

 

(in millions) 

Three months ended

September 30,

  

Nine months ended

September 30,

 
   2023   2022   % Change   2023   2022   % Change 
                         
European based product sales  $233.5   $198.3    18%  $661.5   $546.7    21%
United States based product sales   134.5    82.2    64%   327.4    229.2    43%
   $368.0   $280.5    31%  $988.9   $775.9    27%

 

Net sales for the three months ended September 30, 2023, increased 31% from the three months ended September 30, 2022. At comparable foreign currency exchange rates, net sales increased 27% from the third quarter of 2022 of which 7% is related to new brands. The average dollar/euro exchange rate for the current third quarter was 1.09 compared to 1.01 in the third quarter of 2022, while for the nine months ended September 2023 the average dollar/euro exchange rate was 1.08 compared to 1.06 in the nine months ended September 2022. Net sales for the nine months ended September 30, 2023, increased 27% as compared to the nine months ended September 2022. At comparable foreign currency exchange rates, net sales increased 26% from the nine months ended September 2022 of which 7% is related to new brands.

 

Continuing the trend from the first half of 2023, the current third quarter was exceptionally strong for both European and United States based operations, as net sales increased 18% and 64%, respectively, as compared to the corresponding period of the prior year. As previously disclosed, the third quarter growth rate is favorably impacted by a lower base in 2022 where more gift sets were shipped in the fourth quarter due to supply chain disruptions. We currently expect this phasing to adversely impact our fourth quarter growth rates. 

 

Page 18

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

For European based operations, our largest brands, Coach, Montblanc, and Jimmy Choo sales rose 32%, 20% and 6%, respectively, as compared to the corresponding period of the prior year. Continuing the growth trend of the first half of 2023, third quarter sales by our United States operations grew substantially, up 64%, largely from the continued success of GUESS fragrances which performed exceedingly well during the quarter across all geographies and was up 59% from the third quarter of 2022. This was driven by the continued growth in sales of the Seductive line within GUESS. Of note, the significant growth in the quarter builds upon the 45% sales increase we reported for the third quarter of 2022. We also had strong sales of Ferragamo fragrances, which we have enriched with sister scents for the Signorina and Storie di Seta collections. During the quarter, we initiated Phase 1 of the Abercrombie & Fitch Fierce distribution roll-out. We began with introductory distribution of this iconic fragrance in select markets and expect the majority of the Phase 1 distribution to roll-out during the fourth quarter. The increase was also driven by the addition and extension of Donna Karan and DKNY to our portfolio. They have climbed to become our second largest United States based brand in just one year under our expertise. 

 

The favorable trends in the first half of the year continued into the third quarter and we look forward to executing our plans for the remainder of the year. Our brands are in high demand in a robust environment for the fragrance industry. We have a large number of brand extensions across many of our brands launching in the fourth quarter of the year, including Guess Bella Vita Paradiso. In sum, 2023 has all the earmarks of another superb year as the growth catalysts currently far outweigh the headwinds, most notably the somewhat limited travel retail business in Asia and supply chain disruptions that have largely abated. 

 

Net Sales to Customers by Region  Nine months ended September 30, 
(In millions)  2023   2022 
         
North America  $370.1   $284.7 
Western Europe   242.8    196.3 
Asia   138.1    120.2 
Middle East   82.6    66.3 
Eastern Europe   75.4    45.6 
Central and South America   71.7    56.2 
Other   8.2    6.6 
   $988.9   $775.9 

 

In the first three quarters of 2023, sales in our largest market, North America, rose 30%, followed by Western Europe and Asia where comparable three quarter year sales in both regions increased 24% and 15%, respectively. Our sales in Eastern Europe, Central and South America and the Middle East were also robust, up 65%, 28% and 25%, respectively. Additionally, our travel retail business is continuing to show signs of renewed life.

 

Page 19

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

  Three months ended   Nine months ended 
Gross Profit margin  September 30,   September 30, 
(in millions)  2023   2022   2023   2022 
                 
European operations                    
Net sales  $233.5   $198.2   $661.5   $546.7 
Cost of sales   73.3    60.5    220.6    176.1 
Gross margin  $160.2   $137.7   $440.9   $370.6 
Gross margin as a % of net sales   68.6%   69.5%   66.6%   67.8%
                     
United States operations                    
Net sales  $134.5   $82.2   $327.4   $229.1 
Cost of sales   59.7    38.0    141.9    105.4 
Gross margin  $74.8   $44.2   $185.5   $123.7 
Gross margin as a % of net sales   55.6%   53.8%   56.7%   54.0%

 

The Company’s gross margin percentage was 63.9% and 63.3% for the three and nine months ended September 30, 2023 as compared to 64.9% and 63.7% for the three and nine months ended September 30, 2022, respectively. This decrease in gross margin percentage was largely driven by unfavorable segment mix as well as certain one time expenses related to inventory as discussed further below. Overall, the Company’s pricing actions have broadly compensated for cost inflation impacts. 

 

For European based operations, gross profit margin as a percentage of net sales was 68.6% and 66.6% for the three and nine months ended September 30, 2023, respectively, as compared to 69.5% and 67.8% for the corresponding periods of the prior year. As previously disclosed, a key driver in the decrease in gross profit margin for European based operations in 2023 was due to an increase in inventory reserves in the second quarter of 2023 related to certain underperforming brands. As the Company experienced long lead times in obtaining and building inventory during the COVID-19 Pandemic, high levels of inventory investments were required to protect service levels. Excluding these one-time adjustments, gross margin as a percentage of sales for European based operations would be in line with the prior period, driven by increases in pricing and product mix, offset by cost inflation. 

 

For United States operations, gross profit margin was 55.6% and 56.7% for the three and nine months ended September 30, 2023, respectively, as compared to 53.8% and 54.0% for the corresponding periods of the prior year. The significant margin expansion stems from a number of factors. Firstly, for the most part, the price increases we took in early 2023 weren’t fully offset by a higher cost of goods given our cost containment efforts. Secondly, we are seeing favorable brand and channel mix, as a larger portion of our higher priced fragrances are being sold directly to retailers as opposed to third-party distributors. Lastly, the significant increase in sales in the first three quarters of 2023 allowed us to better absorb fixed expenses such as depreciation and point of sale expenses, as compared to the corresponding period of the prior year. 

 

Page 20

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Generally, we do not bill customers for shipping and handling costs, and such costs, which aggregated $3.9 million and $11.4 million for the three and nine months ended September 30, 2023, respectively, as compared to $5.5 million and $11.0 million for the corresponding periods of the prior year, are included in selling, general and administrative expenses in the consolidated statements of income. As such, our Company’s gross profit may not be comparable to that of other companies, which may include these expenses as a component of cost of goods sold.

 

  Three months ended   Nine months ended, 
Selling, general and administrative expenses  September 30,   September 30, 
(In millions)  2023   2022   2023   2022 
                 
European Operations                    
Selling, general and administrative expenses  $98.7   $83.4   $265.2   $231.2 
Selling, general and administrative expenses as a percent of net sales   42.3%   42.1%   40.1%   42.3%
                     
United States Operations                    
Selling, general and administrative expenses  $49.1   $34.0   $128.7   $92.1 
Selling, general and administrative expenses as a percent of net sales   36.5%   41.4%   39.3%   40.2%

 

The Company has seen selling, general and administrative expenses decrease as a percentage of net sales to 40.2% and 39.8% for the three and nine months ended September 30, 2023 as compared to 41.9% and 41.7% for the three and nine months ended September 30, 2022, respectively. This decrease of selling, general and administrative expenses as a percentage of net sales was largely driven by sales growth for the three and nine month periods allowing to better absorb certain fixed operating costs, and favorable segment mix. 

 

For European operations, selling, general and administrative expenses increased 18% and 15% for the three and nine months ended September 30, 2023, as compared to the corresponding period of the prior year, and represented 42.3% and 40.1% of net sales for the three and nine months ended September 30, 2023, respectively, as compared to 42.1% and 42.3% for the three and nine months ended September 30, 2022, respectively. For United States operations, selling, general and administrative expenses increased 44% and 40% for the three and nine months ended September 30, 2023, as compared to the corresponding period of the prior year, and represented 36.5% and 39.3% of net sales for the three and nine months ended September 30, 2023, respectively, as compared to 41.4% and 40.2% for the three and nine months ended September 30, 2022, respectively. As discussed in more detail below, the decreased selling, general and administrative expenses as a percentage of net sales are primarily the result of high sales growth offset in part by increases in promotion and advertising expenditures as well as the annualization impact of the structural investments of $9.0 million in our United States operations that we made throughout 2022 in order to support the new licenses for the first three quarters of 2023.

 

Promotion and advertising included in selling, general and administrative expenses aggregated $62.8 million and $152.6 million for the three and nine months ended September 30, 2023, respectively, as compared to $44.8 million and $124.9 million for the corresponding periods of the prior year. Promotion and advertising represented 17.1% and 15.4% of net sales for the three and nine months ended September 30, 2023, respectively, as compared to 16.0% and 16.1% for the corresponding periods of the prior year. Promotion and advertising are integral parts of our industry, and we continue to invest heavily to support new product launches and to build brand awareness. We believe that our promotion and advertising efforts have had a beneficial effect on sales. All of our brands have benefited from newly launched and enhanced e-commerce sites in existing markets in collaboration with our retail customers on their e-commerce sites. We also continue to develop and implement omnichannel concepts and compelling content to deliver an integrated consumer experience. Long term, we anticipate that on a full year basis, promotion and advertising expenditures should aggregate approximately 21% of net sales, which is in line with pre-COVID historical averages. 

 

Page 21

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Royalty expense included in selling, general and administrative expenses aggregated $29.1 million and $77.2 million for the three and nine months ended September 30, 2023, respectively, as compared to $23.1 million and $61.4 million for the corresponding periods of the prior year. Royalty expense represented 7.9% and 7.8% of net sales for the three and nine months ended September 30, 2023, as compared to 8.3% and 7.9% of net sales for the corresponding periods of the prior year, due to changes in brand mix.

 

Income from Operations

 

As a result of the above analysis regarding net sales, gross profit margins and selling, general and administrative expenses, our operating margins aggregated 23.7% and 23.5% for the three and nine months ended September 30, 2023, respectively, as compared to 23.0% and 22.1% for the corresponding periods of the prior year. 

 

Other Income and Expense

 

Traditionally, interest expense was primarily related to the financing of brand and licensing acquisitions. The increase in interest expense related to prior year acquisitions is the main driver of the increase in other income and expense during 2023. As previously disclosed, in April 2021 we completed the acquisition of the headquarters of Interparfums SA. The acquisition was financed by a 10-year €120 million (approximately $127.1 million) bank loan which bears interest at one-month Euribor plus 0.75%. Also in 2021, approximately €80 million of the variable rate debt was swapped for variable rate debt with a maximum interest rate of 2%. The swap effectively exchanges the variable interest rate to a fixed rate of approximately 1.1%.

 

We enter into foreign currency forward exchange contracts to manage exposure related to receivables from unaffiliated third parties denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Gains and losses on foreign currency transactions have not been significant. Almost 50% of net sales of our European operations are denominated in U.S. dollars.

 

Interest and investment income represents interest earned on cash and cash equivalents and short-term investments. As of September 30, 2023, short-term investments include approximately $8.8 million of marketable equity securities of other companies in the luxury goods sector. In the first quarter of 2023, the Company sold marketable securities which generated a gain of $3.1 million. The Company purchased additional marketable securities in the second and third quarter of 2023, which generated unrealized losses of $0.5 million in the three months ended September 30, 2023. Interest and investment income for the three months ended September 30, 2022, includes a gain of $2.3 million, resulting from the interest rate swap. For the nine months ended September 30, 2022, the Company recognized a gain of $6.4 million related to the interest rate swap which was largely offset by losses of $5.3 million on marketable equity securities during the same period. 

 

Page 22

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Income Taxes

 

Our consolidated effective tax rate was 23.5% and 22.6% for the nine months ended September 30, 2023 and 2022, respectively. The effective tax rate for European operations was 25% for each of the nine months ended September 30, 2023 and 2022. Our effective tax rate for U.S. operations was 19% for the nine months ended September 30, 2023, as compared to 11% for the corresponding period of the prior year. Our effective tax rate differs from the 21% statutory rate due to benefits received from the exercise of stock options as well as deductions we are allowed for a portion of our foreign derived intangible income, slightly offset by state and local taxes. Additionally, in the third quarter of 2022 our U.S. operations recognized a one-time tax benefit of $2.5 million associated with the 2021 Salvatore Ferragamo acquisition. At the time of the acquisition, we had not recognized deferred tax benefits as there were uncertainties concerning its potential recoverability; however, as of September 30, 2022, the recoverability was deemed likely. Other than as discussed above, we did not experience any significant changes in tax rates, and none were expected in jurisdictions where we operate.

 

Net Income

 

   Three months ended
September 30,
   Nine months ended
September 30,
 
   2023   2022   2023   2022 
(In thousands)                
                 
Net income European operations  $45,965   $42,417   $133,480   $106,722 
Net income United States operations   20,155    10,880    46,066    27,386 
                     
Net income   66,120    53,297    179,546    134,108 
                     
Less: Net income attributable to the noncontrolling interest   12,906    11,874    37,312    29,769 
                     
Net income attributable to Inter Parfums, Inc.  $53,214   $41,423   $142,234   $104,339 

 

Net income attributable to Inter Parfums, Inc. was $53.2 million and $142.2 million for the three and nine months ended September 30, 2023, respectively, as compared to $41.4 million and $104.3 million for the corresponding period of the prior year. Net income attributable to European operations was $46.0 million and $133.5 million for the three and nine months ended September 30, 2023, respectively, as compared to $42.4 million and $106.7 million for the corresponding period of the prior year. Net income attributable to United States operations was $20.2 million and $46.1 million for the three and nine months ended September 30, 2023, respectively, as compared to $10.9 million and $27.4 million for the corresponding period of the prior year. The significant fluctuations in net income for both European operations and United States operations are directly related to the previous discussions relating to changes in sales, gross margin, and selling, general and administrative expenses.

 

Page 23

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

The noncontrolling interest arises from our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 28% of Interparfums SA shares trade on the NYSE Euronext. Net income attributable to the noncontrolling interest is directly related to the profitability of our European operations and aggregated 28% of European operations net income for all periods presented. Net margins attributable to Inter Parfums, Inc. for the nine months ended September 30, 2023 and 2022 aggregated 14.4% and 13.4%, respectively.

 

Liquidity and Capital Resources

 

Our conservative financial tradition has enabled us to amass significant cash balances. As of September 30, 2023, we had $183.5 million in cash, cash equivalents and short-term investments, most of which is held in euro by our European operations and is readily convertible into U.S. dollars. We have not had any liquidity issues to date, and do not expect any liquidity issues relating to such cash and cash equivalents and short-term investments. As of September 30, 2023 short-term investments include approximately $10.2 million of marketable equity securities.

 

As of September 30, 2023, working capital aggregated $514 million and we had a working capital ratio of 2.4 to 1. Approximately 78% of the Company’s total assets are held by European operations, and approximately $245 million of trademarks, licenses and other intangible assets are also held by European operations.

 

The Company is party to a number of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2039. In connection with most of these license agreements, the Company is subject to minimum annual advertising commitments, minimum annual royalties and other commitments. See Item 8. Financial Statements and Supplementary Data – Note 12 – Commitments in our 2022 annual report on Form 10-K which is incorporated by reference herein. Future advertising commitments are estimated based on planned future sales for the license terms that were in effect at December 31, 2022, without consideration for potential renewal periods and do not reflect the fact that our distributors share our advertising obligations.

 

The Company hopes to continue to benefit from its strong financial position to potentially acquire one or more brands, either on a proprietary basis or as a licensee. In July 2023, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Roberto Cavalli brand. This license took effect in July 2023, and we target to start shipping products in January 2024. In December 2022, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Lacoste brand. This new license takes effect January 2024.

 

Cash provided by operating activities aggregated $24.3 million for the nine months ended September 30, 2023, as compared to cash used in operating activities of $8.2 million for the corresponding period of the prior year. For the nine months ended September 30, 2023, working capital items used $169.1 million in cash from operating activities, as compared to $159.2 million in the 2022 period. Although from a cash flow perspective accounts receivable is up 48.6% from year end 2022, the balance is reasonable based on 2023 record sales levels and reflects a combination of high volumes of shipments towards the end of the third quarter as well as some payment schedules extended going into the holiday season. Strong collection activity resulted in day’s sales outstanding decreasing to 72 days, down from 80 days in the corresponding period of the prior year. From a cash flow perspective, inventory levels as of September 30, 2023, increased 26% from year end 2022 in support of our overall sales growth. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold.

 

Page 24

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Cash flows provided by investing activities in 2023 reflect purchases and sales of short-term investments. These investments include certificates of deposit with maturities greater than three months. Approximately $2 million of such certificates of deposit contain penalties where we would forfeit a portion of the interest earned in the event of early withdrawal.

 

Our business is not capital intensive as we do not own any manufacturing facilities. On a full year basis, we typically spend approximately $5.0 million on tools and molds, depending on our new product development calendar. Capital expenditures also include amounts for office fixtures, computer equipment and industrial equipment needed at our distribution centers.

 

Our short-term financing requirements are expected to be met by available cash on hand at September 30, 2023, and short-term credit lines provided by domestic and foreign banks. The principal credit facilities for 2023 consist of a $25 million unsecured revolving line of credit provided by a domestic commercial bank and approximately $8 million in credit lines provided by a consortium of international financial institutions. There was $4.5 million of short-term borrowings outstanding pursuant to these facilities as of September 30, 2023 and no short-term borrowings outstanding as of September 30, 2022.

 

In February 2022, our Board authorized a 100% increase in the annual dividend to $2.00 per share. In February 2023, the Board of Directors further increased the annual dividend to $2.50 per share. The next quarterly cash dividend of $0.625 per share is payable on December 31, 2023, to shareholders of record on December 15, 2023.

 

We believe that funds provided by or used in operations can be supplemented by our present cash position and available credit facilities, so that they will provide us with sufficient resources to meet all present and reasonably foreseeable future operating needs.

 

Inflation rates in the U.S. and foreign countries in which we operate did not have a significant impact on operating results for the nine months ended September 30, 2023.

 

Page 25

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

  

Item 3:QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

General

 

We address certain financial exposures through a controlled program of risk management that primarily consists of the use of derivative financial instruments. We primarily enter into foreign currency forward exchange contracts in order to reduce the effects of fluctuating foreign currency exchange rates. We do not engage in the trading of foreign currency forward exchange contracts or interest rate swaps.

 

Foreign Exchange Risk Management

 

We periodically enter into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and to manage risks related to future sales expected to be denominated in a currency other than our functional currency. We enter into these exchange contracts for periods consistent with our identified exposures. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the receivables and cash flows of Interparfums SA, whose functional currency is the euro. All foreign currency contracts are denominated in currencies of major industrial countries and are with large financial institutions, which are rated as strong investment grade.

 

All derivative instruments are required to be reflected as either assets or liabilities in the balance sheet measured at fair value. Generally, increases or decreases in fair value of derivative instruments will be recognized as gains or losses in earnings in the period of change. If the derivative is designated and qualifies as a cash flow hedge, then the changes in fair value of the derivative instrument will be recorded in other comprehensive income.

 

Before entering into a derivative transaction for hedging purposes, we determine that the change in the value of the derivative will effectively offset the change in the fair value of the hedged item from a movement in foreign currency rates. Then, we measure the effectiveness of each hedge throughout the hedged period. Any hedge ineffectiveness is recognized in the income statement.

 

At September 30, 2023, we had foreign currency contracts in the form of forward exchange contracts of approximately U.S. $58.0 million and GB £2.0 million with maturities of less than one year. We believe that our risk of loss as the result of nonperformance by any of such financial institutions is remote.

 

Interest Rate Risk Management

 

We mitigate interest rate risk by monitoring interest rates, and then determining whether fixed interest rates should be swapped for floating rate debt, or if floating rate debt should be swapped for fixed rate debt.

 

Page 26

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Item 4.CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our Chief Executive Officer and Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rule 13a-15(e)) as of the end of the period covered by this quarterly report on Form 10-Q (the “Evaluation Date”). Based on their review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the Evaluation Date, our Company’s disclosure controls and procedures were effective.

 

Changes in Internal Control Over Financial Reporting

 

There has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) that occurred during the quarterly period covered by this report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Part II. Other Information

 

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds.

 

Item (c).

 

In December 2022, our Board of Directors authorized a share repurchase program for our outstanding common stock. For 2023 the maximum number of shares to be repurchased is 166,060, and the balance available for repurchase under this plan for 2023 is 81,000 shares. Over the course of the first nine months of 2023, the Company repurchased 85,060 shares at a cost of $11.3 million. These shares are classified as treasury shares on the accompanying balance sheet. The Company plans to continue repurchasing shares throughout 2023 under this plan. There were no repurchases of shares during the three months ended September 30, 2023.

 

Items 1. Legal Proceedings, 1A. Risk Factors, 3. Defaults Upon Senior Securities, 4. Mine Safety Disclosures and 5. Other Information, are omitted as they are either not applicable or have been included in Part I. 

 

Page 27

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Item 6.Exhibits.

 

The following documents are filed herewith:

 

Exhibit No. Description Page Number
     
31.1 Certifications required by Rule 13a-14(a) of Chief Executive Officer

30 

     
31.2 Certifications required by Rule 13a-14(a) of Chief Financial Officer and Principal Accounting Officer

31 

     
32.1 Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Executive Officer

32 

     
32.2 Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Financial Officer and Principal Accounting Officer

33 

     
101 Interactive data files  

 

Page 28

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on the 7th day of November 2023.

 

 

    INTER PARFUMS, INC.
     
  By: /s/ Michel Atwood
    Chief Financial Officer
     

 

Page 29

EX-31.1 2 g083828_ex31-1.htm EXHIBIT 31.1

 

INTER PARFUMS, INC. AND SUBSIDIARIES 

 

Exhibit 31.1

 

CERTIFICATIONS

 

I, Jean Madar, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Inter Parfums, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 7, 2023  
   
/s/ Jean Madar  
Jean Madar,
Chief Executive Officer

 

Page 30

EX-31.2 3 g083828_ex31-2.htm EXHIBIT 31.2

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Exhibit 31.2

 

I, Michel Atwood, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Inter Parfums, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 7, 2023  
   
/s/ Michel Atwood  
Michel Atwood  
Chief Financial Officer and  
Principal Accounting Officer  

 

Page 31

EX-32.1 4 g083828_ex32-1.htm EXHIBIT 32.1

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Exhibit 32.1

 

CERTIFICATION

 

The undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Inter Parfums, Inc., that the Quarterly Report of Inter Parfums, Inc. on Form 10-Q for the period ended September 30, 2023, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of Inter Parfums, Inc.

 

Date: November 7, 2023 By: /s/ Jean Madar
    Jean Madar,
    Chief Executive Officer

 

A signed original of this written statement required by Section 906 has been provided to Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

Page 32

EX-32.2 5 g083828_ex32-2.htm EXHIBIT 32.2

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Exhibit 32.2

 

CERTIFICATION

 

The undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Inter Parfums, Inc., that the Quarterly Report of Inter Parfums, Inc. on Form 10-Q for the period ended September 30, 2023, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of Inter Parfums, Inc.

 

Date: November 7, 2023 By: /s/ Michel Atwood
    Michel Atwood
    Chief Financial Officer and
    Principal Accounting Officer

 

A signed original of this written statement required by Section 906 has been provided to Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

Page 33

EX-101.SCH 6 ipar-20230930.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Significant Accounting Policies: link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Impact of COVID-19 Pandemic: link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Recent Agreements: link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Recent Accounting Pronouncements: link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Inventories: link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Fair Value Measurement: link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Derivative Financial Instruments: link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Leases: link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Share-Based Payments: link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Segment and Geographic Areas: link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Inventories: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Fair Value Measurement: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Share-Based Payments: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Segment and Geographic Areas: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Recent Agreements: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Inventories consist of the following: (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Derivative Financial Instruments: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Leases: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023: (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - The following table summarizes stock option information as of September 30, 2023: (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Share-Based Payments: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Information on our operations by geographical areas is as follows: (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ipar-20230930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ipar-20230930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ipar-20230930_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Treasury Stock, Common [Member] Noncontrolling Interest [Member] Business Acquisition [Axis] Roberto Cavalli [Member] Lacoste [Member] Donna Karan and DKNY [Member] Rochas Fashion [Member] Ownership [Axis] Interparfums SA [Member] Long-Lived Tangible Asset [Axis] Land [Member] Building [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Currency [Axis] Euro Member Countries, Euro Derivative Instrument [Axis] Interest Rate Swap [Member] Foreign Exchange Contract [Member] United Kingdom, Pounds Equity Option [Member] Consolidated Entities [Axis] Interparfums SA Subsidiary [Member] Title of Individual [Axis] Employees [Member] Officers and Managers [Member] Geographical [Axis] UNITED STATES Europe [Member] Eliminations [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Short-term investments Accounts receivable, net Inventories Receivables, other Other current assets Income taxes receivable Total current assets Property, equipment and leasehold improvements, net Right-of-use assets, net Trademarks, licenses and other intangible assets, net Deferred tax assets Other assets Total assets LIABILITIES AND EQUITY Current liabilities: Loans payable - banks Current portion of long-term debt Current portion of lease liabilities Accounts payable – trade Accrued expenses Income taxes payable Total current liabilities Long–term debt, less current portion Lease liabilities, less current portion Equity: Inter Parfums, Inc. shareholders’ equity: Preferred stock, $.001 par; authorized 1,000,000 shares; none issued Common stock, $.001 par; authorized 100,000,000 shares; outstanding 31,980,805 and 31,967,300 shares at September 30, 2023 and December 31, 2022, respectively Additional paid-in capital Retained earnings Accumulated other comprehensive loss Treasury stock, at cost, 9,949,865 and 9,864,805 shares at September 30, 2023 and December 31, 2022, respectively Total Inter Parfums, Inc. shareholders’ equity Noncontrolling interest Total equity Total liabilities and equity Preferred stock, par value (in dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Common stock, par value (in dollars per share) Common stock, shares authorized Common stock, shares, outstanding Treasury stock, shares Income Statement [Abstract] Net sales Cost of sales Gross margin Selling, general and administrative expenses Income from operations Other expenses (income): Interest expense (Gain) loss on foreign currency Interest and investment income Other (income) expense Nonoperating expense (income) Income before income taxes Income taxes Net income Less:  Net income attributable to the noncontrolling interest Net income attributable to Inter Parfums, Inc. Earnings per share: Net income attributable to Inter Parfums, Inc. common shareholders:    Basic    Diluted Weighted average number of shares outstanding:    Basic    Diluted Dividends declared per share Comprehensive income: Net income     Other comprehensive income: Net derivative instrument (loss) gain, net of tax Transfer from OCI into earnings Translation adjustments, net of tax Comprehensive income Comprehensive income attributable to the noncontrolling interests:     Net income Net derivative instrument (loss) gain, net of tax Translation adjustments, net of tax Comprehensive income attributable to the noncontrolling interests Comprehensive income attributable to Inter Parfums, Inc. Statement [Table] Statement [Line Items] Beginning Balance Shares issued upon exercise of stock options Dividends Foreign currency translation adjustment, net of tax Share-based compensation Purchase of subsidiary shares Transfer from other comprehensive income into earnings Net derivative instrument gain (loss), net of tax Shares repurchased Purchase of subsidiary shares Ending Balance Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net income to net cash provided by (used in) operating activities: Depreciation and amortization Provision for doubtful accounts Noncash stock compensation Share of income of equity investment Noncash lease expense Deferred tax benefit Change in fair value of derivatives Changes in: Accounts receivable Inventories Other assets Operating lease liabilities Accounts payable and accrued expenses Income taxes, net Net cash provided by (used in) operating activities Cash flows from investing activities: Purchases of short-term investments Proceeds from sale of short-term investments Purchases of property, equipment and leasehold improvements Payment for intangible assets acquired    Net cash provided by (used in) investing activities Cash flows from financing activities: Proceeds from loans payable, bank Proceeds from issuance of long-term debt Repayment of long-term debt Proceeds from exercise of options Purchase of subsidiary shares from noncontrolling interest Dividends paid Dividends paid to noncontrolling interest Purchase of treasury stock    Net cash used in financing activities Effect of exchange rate changes on cash Net decrease in cash and cash equivalents Cash and cash equivalents - beginning of period Cash and cash equivalents - end of period Cash paid for:    Interest    Income taxes Accounting Policies [Abstract] Significant Accounting Policies: Unusual or Infrequent Items, or Both [Abstract] Impact of COVID-19 Pandemic: Business Combination and Asset Acquisition [Abstract] Recent Agreements: Accounting Changes and Error Corrections [Abstract] Recent Accounting Pronouncements: Inventory Disclosure [Abstract] Inventories: Fair Value Disclosures [Abstract] Fair Value Measurement: Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Financial Instruments: Leases [Abstract] Leases: Equity [Abstract] Share-Based Payments: Earnings Per Share [Abstract] Net Income Attributable to Inter Parfums, Inc. Common Shareholders: Segment Reporting [Abstract] Segment and Geographic Areas: Inventories consist of the following: The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023: The following table summarizes stock option information as of September 30, 2023: Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows: The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: Information on our operations by geographical areas is as follows: Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Description of recent agreement Ownership percentage Purchase price, period cost Acquisition costs, period cost Depreciated over a range Cash held in escrow is included in other assets Long-term debt, term Long-term line of credit Description of debt instrument interest rate terms Debt instrument, face amount Variable interest rate Fixed interest rate Raw materials and component parts Finished goods Inventories Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets: Short-term investments Interest rate swaps Total asset Liabilities: Foreign currency forward exchange contracts accounted for using hedge accounting Foreign currency forward exchange contracts not accounted for using hedge accounting Total liabilities Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Line Items] Loan amount Derivative swap interest rate Forward exchange contracts Maturity of foreign currency Operating lease, weighted average remaining lease term Operating lease, weighted average discount rate, percent Operating leases, rent expense, net Operating lease, payments Noncash additions to operating lease assets Nonvested options beginning of period Weighted average grant date fair value, beginning of year Nonvested options granted Weighted average grant date fair value, nonvested options granted Nonvested options vested or forfeited Weighted average grant date fair value, nonvested options vested or forfeited Nonvested options end of period Weighted average grant date fair value, nonvested options end of period Options shares under option - beginning of year Weighted average exercise price shares under option - beginning of year Options forfeited Weighted average exercise price options forfeited Options exercised Weighted average exercise price options exercised Options shares under option - end of year Weighted average exercise price shares under option - end of year Options exercisable Weighted average exercise price options exercisable Options available for future grants Cash proceeds from stock options exercised Tax benefits Intrinsic value of stock options exercised Schedule of Subsidiary or Equity Method Investee [Table] Subsidiary or Equity Method Investee [Line Items] Options vesting period Fair value of shares vested Income before income taxes Share-based payment arrangement, expense Weighted average remaining contractual life of options outstanding (in years) Weighted average remaining contractual life of options exercisable (in years) Aggregate intrinsic value of options outstanding and options outstanding Aggregate intrinsic value of options outstanding and options exercisable Unrecognized compensation cost Options granted Aggregate shares to offices and managers Adjusted for stock splits Recognized as compensation cost Number of share distributed Numerator: Net income attributable to Inter Parfums, Inc. Denominator: Weighted average shares Stock options Denominator for diluted earnings per share Net income attributable to Inter Parfums, Inc. common shareholders: Basic Diluted Antidilutive potential common shares outstanding Schedule of Revenues from External Customers and Long-Lived Assets [Table] Revenues from External Customers and Long-Lived Assets [Line Items] Assets The element represents roberto cavalli member. The element represents lacoste member. The element represents rochas fashion member. The element represents interparfums s a member. The element represents interparfums s a subsidiary member. The element represents employees member. The element represents officers and managers member. The element represents eliminations member. The element represents transfer of subsidiary shares purchased to treasury shares. The element represents donna karan and dkny member. Assets, Current Liabilities, Current Treasury Stock, Value Equity, Attributable to Parent Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Gross Profit Operating Income (Loss) Gain (Loss), Foreign Currency Transaction, before Tax Investment Income, Net Other Nonoperating Income (Expense) Nonoperating Income (Expense) Weighted Average Number of Shares Outstanding, Diluted Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Dividends, Cash Stock Repurchased During Period, Value Transfer of Subsidiary Shares Purchased to Treasury Shares Income (Loss) from Equity Method Investments Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Other Operating Assets Net Cash Provided by (Used in) Operating Activities Payments to Acquire Investments Payments to Acquire Property, Plant, and Equipment Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Repayments of Long-Term Debt Payments to Noncontrolling Interests Payments of Ordinary Dividends, Common Stock Payments of Ordinary Dividends, Noncontrolling Interest Payments for Repurchase of Equity Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Investments, Fair Value Disclosure Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period EX-101.PRE 10 ipar-20230930_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover - shares
9 Months Ended
Sep. 30, 2023
Nov. 07, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2023  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 0-16469  
Entity Registrant Name INTER PARFUMS, INC.  
Entity Central Index Key 0000822663  
Entity Tax Identification Number 13-3275609  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 551 Fifth Avenue  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10176  
City Area Code (212)  
Local Phone Number 983-2640  
Title of 12(b) Security Common Stock, $.001 par value per share  
Trading Symbol IPAR  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   31,980,805
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 79,764 $ 104,713
Short-term investments 103,745 150,833
Accounts receivable, net 288,085 197,584
Inventories 364,270 289,984
Receivables, other 13,645 28,803
Other current assets 26,847 15,650
Income taxes receivable 498 157
Total current assets 876,854 787,724
Property, equipment and leasehold improvements, net 163,002 166,722
Right-of-use assets, net 29,359 27,964
Trademarks, licenses and other intangible assets, net 286,697 290,853
Deferred tax assets 16,063 11,159
Other assets 22,422 24,120
Total assets 1,394,397 1,308,542
Current liabilities:    
Loans payable - banks 4,501
Current portion of long-term debt 41,768 28,547
Current portion of lease liabilities 5,687 5,296
Accounts payable – trade 87,161 88,388
Accrued expenses 200,065 213,621
Income taxes payable 23,913 8,715
Total current liabilities 363,095 344,567
Long–term debt, less current portion 128,983 151,494
Lease liabilities, less current portion 25,452 24,335
Inter Parfums, Inc. shareholders’ equity:    
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued
Common stock, $.001 par; authorized 100,000,000 shares; outstanding 31,980,805 and 31,967,300 shares at September 30, 2023 and December 31, 2022, respectively 32 32
Additional paid-in capital 95,752 90,186
Retained earnings 703,091 620,095
Accumulated other comprehensive loss (59,802) (56,056)
Treasury stock, at cost, 9,949,865 and 9,864,805 shares at September 30, 2023 and December 31, 2022, respectively (48,764) (37,475)
Total Inter Parfums, Inc. shareholders’ equity 690,309 616,782
Noncontrolling interest 186,558 171,364
Total equity 876,867 788,146
Total liabilities and equity $ 1,394,397 $ 1,308,542
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares, outstanding 31,980,805 31,967,300
Treasury stock, shares 9,949,865 9,864,805
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net sales $ 367,969 $ 280,462 $ 988,936 $ 775,865
Cost of sales 132,962 98,562 362,568 281,525
Gross margin 235,007 181,900 626,368 494,340
Selling, general and administrative expenses 147,805 117,424 393,866 323,249
Income from operations 87,202 64,476 232,502 171,091
Other expenses (income):        
Interest expense 2,397 682 7,030 2,589
(Gain) loss on foreign currency (669) 273 (656) (2,245)
Interest and investment income (1,062) (3,343) (8,421) (2,341)
Other (income) expense (77) 346 (125) (98)
Nonoperating expense (income) 589 (2,042) (2,172) (2,095)
Income before income taxes 86,613 66,518 234,674 173,186
Income taxes 20,493 13,221 55,128 39,078
Net income 66,120 53,297 179,546 134,108
Less:  Net income attributable to the noncontrolling interest 12,906 11,874 37,312 29,769
Net income attributable to Inter Parfums, Inc. $ 53,214 $ 41,423 $ 142,234 $ 104,339
Net income attributable to Inter Parfums, Inc. common shareholders:        
   Basic $ 1.66 $ 1.30 $ 4.44 $ 3.28
   Diluted $ 1.66 $ 1.30 $ 4.42 $ 3.26
Weighted average number of shares outstanding:        
   Basic 31,976 31,860 32,000 31,848
   Diluted 32,124 31,968 32,149 31,977
Dividends declared per share $ 0.625 $ 0.50 $ 1.875 $ 1.50
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Comprehensive income:        
Net income $ 66,120 $ 53,297 $ 179,546 $ 134,108
    Other comprehensive income:        
Net derivative instrument (loss) gain, net of tax (363) 1,315 (4,606) (173)
Transfer from OCI into earnings 1,709 992
Translation adjustments, net of tax (15,692) (32,944) (2,657) (79,015)
Comprehensive income 50,065 21,668 173,992 55,912
Comprehensive income attributable to the noncontrolling interests:        
    Net income 12,906 11,874 37,312 29,769
Net derivative instrument (loss) gain, net of tax (100) 362 (327) (49)
Translation adjustments, net of tax (4,892) (10,012) (1,481) (24,174)
Comprehensive income attributable to the noncontrolling interests 7,914 2,224 35,504 5,546
Comprehensive income attributable to Inter Parfums, Inc. $ 42,151 $ 19,444 $ 138,488 $ 50,366
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock, Common [Member]
Noncontrolling Interest [Member]
Total
Beginning Balance at Dec. 31, 2021 $ 32 $ 87,132 $ 560,663 $ (38,432) $ (37,475) $ 166,412 $ 596,040
Net income   104,339     29,769 134,108
Shares issued upon exercise of stock options   1,816          
Dividends     (47,782)     (16,056)  
Foreign currency translation adjustment, net of tax       (54,841)   (24,174)  
Share-based compensation   1,017 1,664     (353)  
Purchase of subsidiary shares   (4,305)       (152)  
Transfer from other comprehensive income into earnings       992      
Net derivative instrument gain (loss), net of tax       (124)   (49) 173
Shares repurchased            
Purchase of subsidiary shares           55  
Ending Balance at Sep. 30, 2022 32 85,660 618,884 (92,405) (37,475) 155,452 730,148
Beginning Balance at Dec. 31, 2022 32 90,186 620,095 (56,056) (37,475) 171,364 788,146
Net income   142,234     37,312 179,546
Shares issued upon exercise of stock options   5,523          
Dividends     (60,058)     (20,301)  
Foreign currency translation adjustment, net of tax       (1,176)   (1,481)  
Share-based compensation   935 820     133  
Purchase of subsidiary shares   (892)       (142)  
Transfer from other comprehensive income into earnings       1,709      
Net derivative instrument gain (loss), net of tax       (4,279)   (327) 4,606
Shares repurchased         (11,289)    
Purchase of subsidiary shares            
Ending Balance at Sep. 30, 2023 $ 32 $ 95,752 $ 703,091 $ (59,802) $ (48,764) $ 697,321 $ 876,867
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net income $ 179,546 $ 134,108
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 12,781 10,936
Provision for doubtful accounts (560) 2,004
Noncash stock compensation 1,887 2,353
Share of income of equity investment (125) (98)
Noncash lease expense 4,163 4,074
Deferred tax benefit (5,075) (3,658)
Change in fair value of derivatives 740 1,348
Changes in:    
Accounts receivable (96,076) (89,605)
Inventories (76,786) (109,377)
Other assets 3,077 2,615
Operating lease liabilities (4,044) (3,887)
Accounts payable and accrued expenses (10,919) 26,406
Income taxes, net 15,669 14,606
Net cash provided by (used in) operating activities 24,278 (8,175)
Cash flows from investing activities:    
Purchases of short-term investments (145,427) (2,862)
Proceeds from sale of short-term investments 192,568 5,346
Purchases of property, equipment and leasehold improvements (4,574) (32,615)
Payment for intangible assets acquired (2,063) (3,757)
   Net cash provided by (used in) investing activities 40,504 (33,888)
Cash flows from financing activities:    
Proceeds from loans payable, bank 4,501
Proceeds from issuance of long-term debt 13,680
Repayment of long-term debt (22,527) (14,210)
Proceeds from exercise of options 5,523 1,816
Purchase of subsidiary shares from noncontrolling interest (4,402)
Dividends paid (60,058) (47,782)
Dividends paid to noncontrolling interest (20,301) (16,056)
Purchase of treasury stock (11,289)
   Net cash used in financing activities (90,471) (80,634)
Effect of exchange rate changes on cash 740 (4,413)
Net decrease in cash and cash equivalents (24,949) (127,110)
Cash and cash equivalents - beginning of period 104,713 168,387
Cash and cash equivalents - end of period 79,764 41,227
Cash paid for:    
   Interest 4,659 2,091
   Income taxes $ 44,693 $ 27,718
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies:
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies:

1.Significant Accounting Policies:

 

The accounting policies we follow are set forth in the notes to our consolidated financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, 2022.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Impact of COVID-19 Pandemic:
9 Months Ended
Sep. 30, 2023
Unusual or Infrequent Items, or Both [Abstract]  
Impact of COVID-19 Pandemic:

2.Impact of COVID-19 Pandemic:

 

Our business has continued to significantly improve throughout 2022 and the first three quarters of 2023 after the disastrous effects of the COVID-19 Pandemic starting in early 2020, as retail stores reopened, and consumers increased online purchasing. While the COVID-19 Pandemic had significantly restricted international travel, the travel retail business has picked up. Lastly, we experienced significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions came at a time when demand for our product lines has never been stronger or more sustained. We have addressed this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. The supply chain bottlenecks have been improving and while lead times remain longer than pre-COVID, we do not expect significant disruptions going forward. 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Recent Agreements:
9 Months Ended
Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Recent Agreements:

3.Recent Agreements:

 

Roberto Cavalli

 

In July 2023, we closed a transaction agreement with Roberto Cavalli, whereby an exclusive and worldwide license was granted for the production and distribution of Roberto Cavalli brand perfumes and fragrance related products. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license became effective in July 2023 and will last for 6.5 years.

 

Lacoste

 

In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.

 

Dunhill

 

The Dunhill fragrance license has expired on September 30, 2023 and will not be renewed. The Company has now entered the twelve month sell-off period during which it will maintain the right to sell-off remaining Dunhill fragrance inventory, which is customary in the fragrance industry. All usable components have been converted to finished goods, and any remaining components will be destroyed. 

 

Donna Karan and DKNY

 

In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we have gained several well-established and valuable fragrance franchises, most notably Donna Karan Cashmere Mist and DKNY Be Delicious, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock to the licensor valued at $5.0 million. The exclusive license became effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024. 

 

Rochas Fashion

 

Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.

 

Land and Building Acquisition - Headquarters in Paris

 

In April 2021, Interparfums SA, our 72% owned French Subsidiary, completed the acquisition of its headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.

 

The purchase price included the complete renovation of the site. As of September 30, 2023, $148.1 million of the purchase price, including approximately $3 million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet. The purchase price has been allocated approximately $60.7 million to land and $87.4 million to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of 7 to 50 years. The Company has elected to depreciate the building cost based on the useful lives of its components. Approximately $1.2 million of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of September 30, 2023.

 

The acquisition was financed by a 10-year €120 million (approximately $127.1 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately €80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. The swap effectively exchanges the variable interest rate to a fixed rate of approximately 1.1%.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Recent Accounting Pronouncements:
9 Months Ended
Sep. 30, 2023
Accounting Changes and Error Corrections [Abstract]  
Recent Accounting Pronouncements:

4.Recent Accounting Pronouncements:

 

There are no recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Inventories:
9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
Inventories:

5.Inventories:

 

Inventories consist of the following:

 

(In thousands) 

September 30,

2023

  

December 31,

2022

 
Raw materials and component parts  $151,344   $146,772 
Finished goods   212,926    143,212 
           
Inventories  $364,270   $289,984 

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurement:
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurement:

6.Fair Value Measurement:

 

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

 

                         
       Fair Value Measurements at September 30, 2023 
       Quoted Prices in   Significant Other   Significant 
       Active Markets for   Observable   Unobservable 
       Identical Assets   Inputs   Inputs 
   Total   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Short-term investments  $103,745   $10,177   $92,776   $792 
Interest rate swaps   6,274        6,274     
                     
Total asset  $110,019   $10,177   $99,050   $792 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting  $791   $   $791   $ 
Foreign currency forward exchange contracts accounted for using hedge accounting   489        489      
                     
 Total liabilities  $1,280   $   $1,280   $ 

 

 

                       
       Fair Value Measurements at December 31, 2022 
       Quoted Prices in   Significant Other   Significant 
       Active Markets for   Observable   Unobservable 
       Identical Assets   Inputs   Inputs 
   Total   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Short-term investments  $150,833   $19,861   $130,174   $798 
Interest rate swaps   6,758        6,758     
Foreign currency forward exchange contracts accounted for using hedge accounting   1,189        1,189     
                     
Total asset  $158,780   $19,861   $138,121   $798 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting   68        68     
                     
Total liabilities  $68   $   $68   $ 

 

The carrying amount of cash and cash equivalents including money market funds, short-term investments, accounts receivable, other receivables, cash held in escrow, accounts payable and accrued expenses approximate fair value due to the short terms to maturity of these instruments.

 

The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.

 

Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net present value of the swaps using third party quotes from financial institutions.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Derivative Financial Instruments:
9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments:

7.Derivative Financial Instruments:

 

The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings. 

 

In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a €50 million (approximately $53 million) 4-year term loan with a variable interest rate. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. This swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.

 

In connection with the April 2021 acquisition of the office building complex in Paris, €120 million (approximately $127.1 million) of the purchase price was financed through a 10-year term loan. The Company entered into interest rate swap contracts related to €80 million of the loan, effectively exchanging the variable interest rate to a fixed rate of approximately 1.1%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

 

Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial for the three and nine months ended September 30, 2023 and 2022.

 

All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swaps is included in other assets on the accompanying balance sheets. The valuation of foreign currency forward exchange contracts at September 30, 2023 resulted in a net asset and is included in other current assets on the accompanying balance sheet.

 

At September 30, 2023, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $58.0 million and GB £2.0 million which all have maturities of less than one year.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Leases:
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Leases:

8.Leases:

 

The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.

 

In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.

 

As of September 30, 2023, the weighted average remaining lease term was 5.4 years and the weighted average discount rate used to determine the operating lease liability was 3.0%. Rental expense related to operating leases was $1.5 million and $4.5 million for the three and nine months ended September 30, 2023, respectively, as compared to $1.2 million and $4.3 million for the corresponding periods of the prior year. Operating lease payments included in operating cash flows totaled $4.0 million and $3.9 million for the nine months ended September 30, 2023 and 2022, respectively, and noncash additions to operating lease assets totaled $5.7 million and $0.5 million for the nine months ended September 30, 2023 and 2022, respectively.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Payments:
9 Months Ended
Sep. 30, 2023
Equity:  
Share-Based Payments:

9.Share-Based Payments:

 

The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to five-year period. The fair value of shares vested during the nine months ended September 30, 2023 and 2022 aggregated $0.10 million and $0.11 million, respectively. Compensation cost, net of forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options.

 

The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023:

 

  

Number of

Shares

  

Weighted

Average

Grant-Date

Fair Value

 
Nonvested options – beginning of period   168,730   $16.31 
Nonvested options granted        
Nonvested options vested or forfeited   (27,625)  $13.91 
Nonvested options – end of period   141,105   $16.78 

 

Share-based payment expense decreased income before income taxes by $0.62 million and $1.89 million for the three and nine months ended September 30, 2023, respectively, as compared to $0.47 million and $2.35 million for the corresponding periods of the prior year. Share-based payment expense decreased income attributable to Inter Parfums, Inc. by $0.41 million and $1.27 million for the three and nine months ended September 30, 2023, respectively, as compared to $0.34 million and $1.52 million for the corresponding periods of the prior year.

 

The following table summarizes stock option information as of September 30, 2023:

 

   Shares  

Weighted

Average

Exercise Price

 
         
Outstanding at January 1, 2023   441,580   $67.30 
Options forfeited   (20,025)   72.22 
Options exercised   (98,565)   56.03 
           
Outstanding at September 30, 2023   322,990   $70.43 
          
Options exercisable   181,885   $61.44 
Options available for future grants   579,000      

 

As of September 30, 2023, the weighted average remaining contractual life of options outstanding is 2.15 years (0.34 years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $20.64 million and $13.26 million, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $1.7 million.

 

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows:

 

(In thousands)  September 30, 
2023
   September 30, 
2022
 
         
Cash proceeds from stock options exercised  $5,523   $1,816 
Tax benefits   900    320 
Intrinsic value of stock options exercised   6,135    2,105 

 

There were no options granted during the nine months ended September 30, 2023 and September 30, 2022.

 

Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would increase as the earnings of the Company and its stock price continues to increase.

 

In December 2018, Interparfums SA approved a plan to grant an aggregate of 26,600 shares of its stock to employees with no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate performance conditions. The corporate performance conditions were met and therefore in June 2022, 211,955 shares, adjusted for stock splits, were distributed. The aggregate cost of the grant of approximately $4.8 million was recognized as compensation cost on a straight-line basis over the requisite three-year service period.

 

In March 2022, Interparfums SA approved an additional plan to grant an aggregate of 88,400 shares to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.

 

The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the NYSE Euronext on the date of grant. The estimated number of shares to be distributed of 92,998 has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $4.2 million will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.

 

Similar to the December 2018 plan, in order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. As of September 30, 2023 the Company acquired 87,609 shares at an aggregate cost of $4.1 million.

 

All share purchases and issuances have been classified as equity transactions on the accompanying balance sheet.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Net Income Attributable to Inter Parfums, Inc. Common Shareholders:
9 Months Ended
Sep. 30, 2023
Earnings per share:  
Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

 

10.Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

 

Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.

 

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

                             
   Three months ended   Nine months ended 
(In thousands)  September 30,   September 30, 
   2023   2022   2023   2022 
Numerator:                
Net income attributable to Inter Parfums, Inc.  $53,214   $41,423   $142,234   $104,339 
Denominator:                    
Weighted average shares   31,976    31,860    32,000    31,848 
Effect of dilutive securities:                    
Stock options   148    108    149    129 
Denominator for diluted earnings per share   32,124    31,968    32,149    31,977 
                     
Earnings per share:                    
Net income attributable to Inter
Parfums, Inc. common shareholders:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic  $1.66   $1.30   $4.44   $3.28 
Diluted   1.66    1.30    4.42    3.26 

 

There were no antidilutive potential common shares outstanding for the three and nine months ended September 30, 2023. Not included in the above computations are the effect of antidilutive potential common shares which consist of outstanding options to purchase 0.15 million shares of common stock for both the three and nine months ended September 30, 2022, respectively.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Segment and Geographic Areas:
9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Segment and Geographic Areas:

 

11.Segment and Geographic Areas:

 

The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European operations and United States operations primarily represent the sale of prestige brand name fragrances.

 

Information on our operations by geographical areas is as follows:

 

(In thousands)  Three months ended
September 30,
   Nine months ended
September 30,
 
   2023   2022   2023   2022 
Net sales:                    
United States  $134,469   $82,183   $327,359   $229,129 
Europe   233,500    198,318    661,577    546,787 
Eliminations       (39)       (51)
                     
   $367,969   $280,462   $988,936   $775,865 
                     
Net income attributable to Inter Parfums, Inc.:                    
United States  $20,157   $10,881   $46,067   $27,386 
Europe   33,057    30,542    96,167    76,953 
                     
   $53,214   $41,423   $142,234   $104,339 
                     
             September 30,   December 31, 
             2023   2022 
Total Assets:                    
United States            $340,375   $278,090 
Europe             1,083,843    1,052,004 
Eliminations             (29,821)   (21,552)
             $1,394,397   $1,308,542 

 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Inventories: (Tables)
9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
Inventories consist of the following:

Inventories consist of the following:

 

(In thousands) 

September 30,

2023

  

December 31,

2022

 
Raw materials and component parts  $151,344   $146,772 
Finished goods   212,926    143,212 
           
Inventories  $364,270   $289,984 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurement: (Tables)
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

 

                         
       Fair Value Measurements at September 30, 2023 
       Quoted Prices in   Significant Other   Significant 
       Active Markets for   Observable   Unobservable 
       Identical Assets   Inputs   Inputs 
   Total   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Short-term investments  $103,745   $10,177   $92,776   $792 
Interest rate swaps   6,274        6,274     
                     
Total asset  $110,019   $10,177   $99,050   $792 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting  $791   $   $791   $ 
Foreign currency forward exchange contracts accounted for using hedge accounting   489        489      
                     
 Total liabilities  $1,280   $   $1,280   $ 

 

 

                       
       Fair Value Measurements at December 31, 2022 
       Quoted Prices in   Significant Other   Significant 
       Active Markets for   Observable   Unobservable 
       Identical Assets   Inputs   Inputs 
   Total   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Short-term investments  $150,833   $19,861   $130,174   $798 
Interest rate swaps   6,758        6,758     
Foreign currency forward exchange contracts accounted for using hedge accounting   1,189        1,189     
                     
Total asset  $158,780   $19,861   $138,121   $798 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting   68        68     
                     
Total liabilities  $68   $   $68   $ 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Payments: (Tables)
9 Months Ended
Sep. 30, 2023
Equity:  
The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023:

The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023:

 

  

Number of

Shares

  

Weighted

Average

Grant-Date

Fair Value

 
Nonvested options – beginning of period   168,730   $16.31 
Nonvested options granted        
Nonvested options vested or forfeited   (27,625)  $13.91 
Nonvested options – end of period   141,105   $16.78 
The following table summarizes stock option information as of September 30, 2023:

The following table summarizes stock option information as of September 30, 2023:

 

   Shares  

Weighted

Average

Exercise Price

 
         
Outstanding at January 1, 2023   441,580   $67.30 
Options forfeited   (20,025)   72.22 
Options exercised   (98,565)   56.03 
           
Outstanding at September 30, 2023   322,990   $70.43 
          
Options exercisable   181,885   $61.44 
Options available for future grants   579,000      
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows:

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows:

 

(In thousands)  September 30, 
2023
   September 30, 
2022
 
         
Cash proceeds from stock options exercised  $5,523   $1,816 
Tax benefits   900    320 
Intrinsic value of stock options exercised   6,135    2,105 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables)
9 Months Ended
Sep. 30, 2023
Earnings per share:  
The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

                             
   Three months ended   Nine months ended 
(In thousands)  September 30,   September 30, 
   2023   2022   2023   2022 
Numerator:                
Net income attributable to Inter Parfums, Inc.  $53,214   $41,423   $142,234   $104,339 
Denominator:                    
Weighted average shares   31,976    31,860    32,000    31,848 
Effect of dilutive securities:                    
Stock options   148    108    149    129 
Denominator for diluted earnings per share   32,124    31,968    32,149    31,977 
                     
Earnings per share:                    
Net income attributable to Inter
Parfums, Inc. common shareholders:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic  $1.66   $1.30   $4.44   $3.28 
Diluted   1.66    1.30    4.42    3.26 

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Segment and Geographic Areas: (Tables)
9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Information on our operations by geographical areas is as follows:

Information on our operations by geographical areas is as follows:

 

(In thousands)  Three months ended
September 30,
   Nine months ended
September 30,
 
   2023   2022   2023   2022 
Net sales:                    
United States  $134,469   $82,183   $327,359   $229,129 
Europe   233,500    198,318    661,577    546,787 
Eliminations       (39)       (51)
                     
   $367,969   $280,462   $988,936   $775,865 
                     
Net income attributable to Inter Parfums, Inc.:                    
United States  $20,157   $10,881   $46,067   $27,386 
Europe   33,057    30,542    96,167    76,953 
                     
   $53,214   $41,423   $142,234   $104,339 
                     
             September 30,   December 31, 
             2023   2022 
Total Assets:                    
United States            $340,375   $278,090 
Europe             1,083,843    1,052,004 
Eliminations             (29,821)   (21,552)
             $1,394,397   $1,308,542 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Recent Agreements: (Details Narrative)
9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2023
EUR (€)
Dec. 31, 2022
Apr. 30, 2021
Business Acquisition [Line Items]        
Purchase price, period cost $ 148,100,000      
Acquisition costs, period cost 3,000,000      
Cash held in escrow is included in other assets $ 1,200,000      
Long-term debt, term 10 years 10 years 4 years 10 years
Long-term line of credit $ 127,100,000 € 120,000,000    
Description of debt instrument interest rate terms one-month Euribor plus 0.75%      
Debt instrument, face amount | €   € 80,000,000    
Variable interest rate 2.00% 2.00%    
Fixed interest rate 1.10% 1.10%    
Minimum [Member]        
Business Acquisition [Line Items]        
Depreciated over a range 7 years 7 years    
Maximum [Member]        
Business Acquisition [Line Items]        
Depreciated over a range 50 years 50 years    
Land [Member]        
Business Acquisition [Line Items]        
Purchase price, period cost $ 60,700,000      
Building [Member]        
Business Acquisition [Line Items]        
Purchase price, period cost $ 87,400,000      
Interparfums SA [Member]        
Business Acquisition [Line Items]        
Ownership percentage       72.00%
Roberto Cavalli [Member]        
Business Acquisition [Line Items]        
Description of recent agreement The license became effective in July 2023 and will last for 6.5 years.      
Lacoste [Member]        
Business Acquisition [Line Items]        
Description of recent agreement The license becomes effective in January 2024 and will last for 15 years.      
Donna Karan and DKNY [Member]        
Business Acquisition [Line Items]        
Description of recent agreement In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock to the licensor valued at $5.0 million. The exclusive license became effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.      
Rochas Fashion [Member]        
Business Acquisition [Line Items]        
Description of recent agreement we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.      
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Inventories consist of the following: (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Raw materials and component parts $ 151,344 $ 146,772
Finished goods 212,926 143,212
Inventories $ 364,270 $ 289,984
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details) - Fair Value, Recurring [Member] - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Assets:    
Short-term investments $ 103,745 $ 150,833
Interest rate swaps 6,274 6,758
Total asset 110,019 158,780
Liabilities:    
Foreign currency forward exchange contracts accounted for using hedge accounting 791 1,189
Foreign currency forward exchange contracts not accounted for using hedge accounting 489 68
Total liabilities 1,280 68
Fair Value, Inputs, Level 1 [Member]    
Assets:    
Short-term investments 10,177 19,861
Interest rate swaps
Total asset 10,177 19,861
Liabilities:    
Foreign currency forward exchange contracts accounted for using hedge accounting
Foreign currency forward exchange contracts not accounted for using hedge accounting
Total liabilities
Fair Value, Inputs, Level 2 [Member]    
Assets:    
Short-term investments 92,776 130,174
Interest rate swaps 6,274 6,758
Total asset 99,050 138,121
Liabilities:    
Foreign currency forward exchange contracts accounted for using hedge accounting 791 1,189
Foreign currency forward exchange contracts not accounted for using hedge accounting 489 68
Total liabilities 1,280 68
Fair Value, Inputs, Level 3 [Member]    
Assets:    
Short-term investments 792 798
Interest rate swaps
Total asset 792 798
Liabilities:    
Foreign currency forward exchange contracts accounted for using hedge accounting
Foreign currency forward exchange contracts not accounted for using hedge accounting
Total liabilities
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Derivative Financial Instruments: (Details Narrative)
€ in Millions, £ in Millions, $ in Millions
9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2023
GBP (£)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
EUR (€)
Apr. 30, 2021
USD ($)
Apr. 30, 2021
EUR (€)
Derivative Instruments, Gain (Loss) [Line Items]            
Loan amount | $     $ 53.0   $ 127.1  
Long-term debt, term 10 years 10 years 4 years 4 years 10 years 10 years
Derivative swap interest rate     2.00% 2.00% 1.10% 1.10%
Foreign Exchange Contract [Member]            
Derivative Instruments, Gain (Loss) [Line Items]            
Forward exchange contracts | $ $ 58.0          
Maturity of foreign currency 1 year          
Euro Member Countries, Euro            
Derivative Instruments, Gain (Loss) [Line Items]            
Loan amount | €       € 50   € 120
Euro Member Countries, Euro | Interest Rate Swap [Member]            
Derivative Instruments, Gain (Loss) [Line Items]            
Loan amount | €           € 80
United Kingdom, Pounds | Foreign Exchange Contract [Member]            
Derivative Instruments, Gain (Loss) [Line Items]            
Loan amount | £   £ 2        
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Leases: (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Leases [Abstract]        
Operating lease, weighted average remaining lease term 5 years 4 months 24 days   5 years 4 months 24 days  
Operating lease, weighted average discount rate, percent 3.00%   3.00%  
Operating leases, rent expense, net $ 1,500,000 $ 1,200,000 $ 4,500,000 $ 4,300,000
Operating lease, payments     4,000,000 3,900,000
Noncash additions to operating lease assets     $ 5,700,000 $ 500,000
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023: (Details)
9 Months Ended
Sep. 30, 2023
$ / shares
shares
Equity:  
Nonvested options beginning of period | shares 168,730
Weighted average grant date fair value, beginning of year | $ / shares $ 16.31
Nonvested options granted | shares
Weighted average grant date fair value, nonvested options granted | $ / shares
Nonvested options vested or forfeited | shares (27,625)
Weighted average grant date fair value, nonvested options vested or forfeited | $ / shares $ 13.91
Nonvested options end of period | shares 141,105
Weighted average grant date fair value, nonvested options end of period | $ / shares $ 16.78
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
The following table summarizes stock option information as of September 30, 2023: (Details)
9 Months Ended
Sep. 30, 2023
$ / shares
shares
Equity:  
Options shares under option - beginning of year 441,580
Weighted average exercise price shares under option - beginning of year | $ / shares $ 67.30
Options forfeited (20,025)
Weighted average exercise price options forfeited | $ / shares $ 72.22
Options exercised (98,565)
Weighted average exercise price options exercised | $ / shares $ 56.03
Options shares under option - end of year 322,990
Weighted average exercise price shares under option - end of year | $ / shares $ 70.43
Options exercisable 181,885
Weighted average exercise price options exercisable | $ / shares $ 61.44
Options available for future grants 579,000
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows: (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Equity:    
Cash proceeds from stock options exercised $ 5,523 $ 1,816
Tax benefits 900 320
Intrinsic value of stock options exercised $ 6,135 $ 2,105
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Payments: (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jun. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Mar. 31, 2022
Dec. 31, 2018
Subsidiary or Equity Method Investee [Line Items]              
Income before income taxes   $ 86,613,000 $ 66,518,000 $ 234,674,000 $ 173,186,000    
Share-based payment arrangement, expense   410,000 $ 340,000 $ 1,270,000 $ 1,520,000    
Weighted average remaining contractual life of options outstanding (in years)       2 years 1 month 24 days      
Weighted average remaining contractual life of options exercisable (in years)       4 months 2 days      
Aggregate intrinsic value of options outstanding and options outstanding   20,640,000   $ 20,640,000      
Aggregate intrinsic value of options outstanding and options exercisable   13,260,000   13,260,000      
Unrecognized compensation cost   $ 1,700,000   $ 1,700,000      
Options granted       0 0    
Adjusted for stock splits 211,955            
Recognized as compensation cost $ 4,800,000            
Interparfums SA Subsidiary [Member]              
Subsidiary or Equity Method Investee [Line Items]              
Recognized as compensation cost       $ 4,200,000      
Interparfums SA Subsidiary [Member] | Employees [Member]              
Subsidiary or Equity Method Investee [Line Items]              
Aggregate shares to offices and managers   87,609   87,609   88,400 26,600
Recognized as compensation cost       $ 4,100,000      
Number of share distributed       92,998      
Interparfums SA Subsidiary [Member] | Officers and Managers [Member]              
Subsidiary or Equity Method Investee [Line Items]              
Aggregate shares to offices and managers             133,000
Equity Option [Member]              
Subsidiary or Equity Method Investee [Line Items]              
Fair value of shares vested       $ 100,000 $ 110,000    
Equity Option [Member] | Minimum [Member]              
Subsidiary or Equity Method Investee [Line Items]              
Options vesting period       4 years      
Equity Option [Member] | Maximum [Member]              
Subsidiary or Equity Method Investee [Line Items]              
Options vesting period       5 years      
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3
The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Numerator:        
Net income attributable to Inter Parfums, Inc. $ 53,214 $ 41,423 $ 142,234 $ 104,339
Denominator:        
Weighted average shares 31,976 31,860 32,000 31,848
Stock options 148 108 149 129
Denominator for diluted earnings per share 32,124 31,968 32,149 31,977
Net income attributable to Inter Parfums, Inc. common shareholders:        
Basic $ 1.66 $ 1.30 $ 4.44 $ 3.28
Diluted $ 1.66 $ 1.30 $ 4.42 $ 3.26
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Earnings per share:        
Antidilutive potential common shares outstanding 0 150,000 0 150,000
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Information on our operations by geographical areas is as follows: (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]          
Net sales $ 367,969 $ 280,462 $ 988,936 $ 775,865  
Net income attributable to Inter Parfums, Inc. 53,214 41,423 142,234 104,339  
Assets 1,394,397   1,394,397   $ 1,308,542
UNITED STATES          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Net sales 134,469 82,183 327,359 229,129  
Net income attributable to Inter Parfums, Inc. 20,157 10,881 46,067 27,386  
Assets 340,375   340,375   278,090
Europe [Member]          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Net sales 233,500 198,318 661,577 546,787  
Net income attributable to Inter Parfums, Inc. 33,057 30,542 96,167 76,953  
Assets 1,083,843   1,083,843   1,052,004
Eliminations [Member]          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Net sales $ (39) $ (51)  
Assets $ (29,821)   $ (29,821)   $ (21,552)
XML 46 g083828_10q_htm.xml IDEA: XBRL DOCUMENT 0000822663 2023-01-01 2023-09-30 0000822663 2023-11-07 0000822663 2023-09-30 0000822663 2022-12-31 0000822663 2023-07-01 2023-09-30 0000822663 2022-07-01 2022-09-30 0000822663 2022-01-01 2022-09-30 0000822663 us-gaap:CommonStockMember 2022-12-31 0000822663 us-gaap:CommonStockMember 2021-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000822663 us-gaap:RetainedEarningsMember 2022-12-31 0000822663 us-gaap:RetainedEarningsMember 2021-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000822663 us-gaap:TreasuryStockCommonMember 2022-12-31 0000822663 us-gaap:TreasuryStockCommonMember 2021-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2021-12-31 0000822663 2021-12-31 0000822663 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0000822663 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0000822663 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0000822663 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0000822663 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-09-30 0000822663 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-09-30 0000822663 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-09-30 0000822663 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-09-30 0000822663 us-gaap:CommonStockMember 2023-09-30 0000822663 us-gaap:CommonStockMember 2022-09-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000822663 us-gaap:RetainedEarningsMember 2023-09-30 0000822663 us-gaap:RetainedEarningsMember 2022-09-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000822663 us-gaap:TreasuryStockCommonMember 2023-09-30 0000822663 us-gaap:TreasuryStockCommonMember 2022-09-30 0000822663 us-gaap:NoncontrollingInterestMember 2023-09-30 0000822663 us-gaap:NoncontrollingInterestMember 2022-09-30 0000822663 2022-09-30 0000822663 ipar:RobertoCavalliMember 2023-01-01 2023-09-30 0000822663 ipar:LacosteMember 2023-01-01 2023-09-30 0000822663 ipar:DonnaKaranAndDKNYMember 2023-01-01 2023-09-30 0000822663 ipar:RochasFashionMember 2023-01-01 2023-09-30 0000822663 ipar:InterparfumsSAMember 2021-04-30 0000822663 us-gaap:LandMember 2023-01-01 2023-09-30 0000822663 us-gaap:BuildingMember 2023-01-01 2023-09-30 0000822663 srt:MinimumMember 2023-09-30 0000822663 srt:MaximumMember 2023-09-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0000822663 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0000822663 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0000822663 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 currency:EUR 2022-12-31 0000822663 currency:EUR 2021-04-30 0000822663 2021-04-30 0000822663 currency:EUR us-gaap:InterestRateSwapMember 2021-04-30 0000822663 us-gaap:ForeignExchangeContractMember 2023-09-30 0000822663 currency:GBP us-gaap:ForeignExchangeContractMember 2023-09-30 0000822663 us-gaap:ForeignExchangeContractMember 2023-01-01 2023-09-30 0000822663 srt:MinimumMember us-gaap:StockOptionMember 2023-01-01 2023-09-30 0000822663 srt:MaximumMember us-gaap:StockOptionMember 2023-01-01 2023-09-30 0000822663 us-gaap:StockOptionMember 2023-01-01 2023-09-30 0000822663 us-gaap:StockOptionMember 2022-01-01 2022-09-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2018-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:OfficersAndManagersMember 2018-12-31 0000822663 2022-06-01 2022-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2023-01-01 2023-09-30 0000822663 ipar:InterparfumsSASubsidiaryMember 2023-01-01 2023-09-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2023-09-30 0000822663 country:US 2023-07-01 2023-09-30 0000822663 country:US 2022-07-01 2022-09-30 0000822663 country:US 2023-01-01 2023-09-30 0000822663 country:US 2022-01-01 2022-09-30 0000822663 srt:EuropeMember 2023-07-01 2023-09-30 0000822663 srt:EuropeMember 2022-07-01 2022-09-30 0000822663 srt:EuropeMember 2023-01-01 2023-09-30 0000822663 srt:EuropeMember 2022-01-01 2022-09-30 0000822663 ipar:EliminationsMember 2023-07-01 2023-09-30 0000822663 ipar:EliminationsMember 2022-07-01 2022-09-30 0000822663 ipar:EliminationsMember 2023-01-01 2023-09-30 0000822663 ipar:EliminationsMember 2022-01-01 2022-09-30 0000822663 country:US 2023-09-30 0000822663 country:US 2022-12-31 0000822663 srt:EuropeMember 2023-09-30 0000822663 srt:EuropeMember 2022-12-31 0000822663 ipar:EliminationsMember 2023-09-30 0000822663 ipar:EliminationsMember 2022-12-31 iso4217:USD shares iso4217:USD shares pure iso4217:EUR iso4217:GBP iso4217:JPY false 2023 Q3 --12-31 0000822663 NY P7Y P50Y P10Y 120000000 80000000 P4Y P10Y P1Y P5Y4M24D 4000000 P4Y P5Y 86613000 234674000 86613000 234674000 P2Y1M24D P0Y4M2D 10-Q true 2023-09-30 false 0-16469 INTER PARFUMS, INC. DE 13-3275609 551 Fifth Avenue New York 10176 (212) 983-2640 Common Stock, $.001 par value per share IPAR NASDAQ Yes Yes Large Accelerated Filer false false false 31980805 79764000 104713000 103745000 150833000 288085000 197584000 364270000 289984000 13645000 28803000 26847000 15650000 498000 157000 876854000 787724000 163002000 166722000 29359000 27964000 286697000 290853000 16063000 11159000 22422000 24120000 1394397000 1308542000 4501000 41768000 28547000 5687000 5296000 87161000 88388000 200065000 213621000 23913000 8715000 363095000 344567000 128983000 151494000 25452000 24335000 0.001 0.001 1000000 1000000 0 0 0.001 0.001 100000000 100000000 31980805 31967300 32000 32000 95752000 90186000 703091000 620095000 -59802000 -56056000 9949865 9864805 48764000 37475000 690309000 616782000 186558000 171364000 876867000 788146000 1394397000 1308542000 367969000 280462000 988936000 775865000 132962000 98562000 362568000 281525000 235007000 181900000 626368000 494340000 147805000 117424000 393866000 323249000 87202000 64476000 232502000 171091000 2397000 682000 7030000 2589000 669000 -273000 656000 2245000 1062000 3343000 8421000 2341000 77000 -346000 125000 98000 -589000 2042000 2172000 2095000 86613000 66518000 234674000 173186000 20493000 13221000 55128000 39078000 66120000 53297000 179546000 134108000 12906000 11874000 37312000 29769000 53214000 41423000 142234000 104339000 1.66 1.30 4.44 3.28 1.66 1.30 4.42 3.26 31976 31860 32000 31848 32124 31968 32149 31977 0.625 0.50 1.875 1.50 66120000 53297000 179546000 134108000 363000 -1315000 4606000 173000 -1709000 -992000 -15692000 -32944000 -2657000 -79015000 50065000 21668000 173992000 55912000 12906000 11874000 37312000 29769000 -100000 362000 -327000 -49000 4892000 10012000 1481000 24174000 7914000 2224000 35504000 5546000 42151000 19444000 138488000 50366000 32000 32000 32000 32000 90186000 87132000 5523000 1816000 935000 1017000 -892000 -4305000 95752000 85660000 620095000 560663000 142234000 104339000 60058000 47782000 820000 1664000 703091000 618884000 -56056000 -38432000 -1176000 -54841000 1709000 992000 -4279000 -124000 -59802000 -92405000 -37475000 -37475000 11289000 -48764000 -37475000 171364000 166412000 37312000 29769000 -1481000 -24174000 -327000 -49000 133000 -353000 -142000 -152000 55000 20301000 16056000 697321000 155452000 788146000 596040000 179546000 134108000 876867000 730148000 179546000 134108000 12781000 10936000 -560000 2004000 1887000 2353000 125000 98000 4163000 4074000 -5075000 -3658000 740000 1348000 96076000 89605000 76786000 109377000 -3077000 -2615000 -4044000 -3887000 -10919000 26406000 15669000 14606000 24278000 -8175000 145427000 2862000 192568000 5346000 4574000 32615000 2063000 3757000 40504000 -33888000 4501000 13680000 22527000 14210000 5523000 1816000 4402000 60058000 47782000 20301000 16056000 11289000 -90471000 -80634000 740000 -4413000 -24949000 -127110000 104713000 168387000 79764000 41227000 4659000 2091000 44693000 27718000 <p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zFBKgDbTi84e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_828_z6h2jEwB6La3">Significant Accounting Policies:</span></span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounting policies we follow are set forth in the notes to our consolidated financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, 2022.</span></p> <p id="xdx_80B_eus-gaap--UnusualOrInfrequentItemsDisclosureTextBlock_zm0mwJ2fkF32" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_825_zcj3AcchEIo3">Impact of COVID-19 Pandemic:</span></span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our business has continued to significantly improve throughout 2022 and the first three quarters of 2023 after the disastrous effects of the COVID-19 Pandemic starting in early 2020, as retail stores reopened, and consumers increased online purchasing. While the COVID-19 Pandemic had significantly restricted international travel, the travel retail business has picked up. Lastly, we experienced significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions came at a time when demand for our product lines has never been stronger or more sustained. We have addressed this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. The supply chain bottlenecks have been improving and while lead times remain longer than pre-COVID, we do not expect significant disruptions going forward. </span></p> <p id="xdx_80F_eus-gaap--BusinessCombinationDisclosureTextBlock_ztzoZJFt0PCd" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in; text-align: justify"></td><td style="width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_824_zkfYddgDfDf5">Recent Agreements:</span></span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Roberto Cavalli</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2023, we closed a transaction agreement with Roberto Cavalli, whereby an exclusive and worldwide license was granted for the production and distribution of Roberto Cavalli brand perfumes and fragrance related products. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. <span id="xdx_904_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20230101__20230930__us-gaap--BusinessAcquisitionAxis__custom--RobertoCavalliMember_z488itYXPUq3" title="Description of recent agreement">The license became effective in July 2023 and will last for 6.5 years.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lacoste</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. <span id="xdx_90A_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20230101__20230930__us-gaap--BusinessAcquisitionAxis__custom--LacosteMember_zabVo3Hb3Rgi" title="Description of recent agreement">The license becomes effective in January 2024 and will last for 15 years.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dunhill</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Dunhill fragrance license has expired on September 30, 2023 and will not be renewed. The Company has now entered the twelve month sell-off period during which it will maintain the right to sell-off remaining Dunhill fragrance inventory, which is customary in the fragrance industry. All usable components have been converted to finished goods, and any remaining components will be destroyed. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Donna Karan and DKNY</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we have gained several well-established and valuable fragrance franchises, most notably Donna Karan <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal consumer base around the world. <span id="xdx_90C_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20230101__20230930__us-gaap--BusinessAcquisitionAxis__custom--DonnaKaranAndDKNYMember_zLDVvqlcjeRg" title="Description of recent agreement">In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock to the licensor valued at $5.0 million. The exclusive license became effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span title="Description of recent agreement"></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rochas Fashion</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 1, 2021, <span id="xdx_90E_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20230101__20230930__us-gaap--BusinessAcquisitionAxis__custom--RochasFashionMember_zznlmEFwBKK9" title="Description of recent agreement">we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Land and Building Acquisition - Headquarters in Paris</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2021, Interparfums SA, our <span id="xdx_907_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20210430__srt--OwnershipAxis__custom--InterparfumsSAMember_zo72ZsxY8n1b" title="Ownership percentage">72</span>% owned French Subsidiary, completed the acquisition of its headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price included the complete renovation of the site. As of September 30, 2023, $<span id="xdx_90A_eus-gaap--PaymentsToAcquireProductiveAssets_dm_uUSD_c20230101__20230930_zKMfYCj3n2z6" title="Purchase price, period cost">148.1 million</span> of the purchase price, including approximately $<span id="xdx_904_eus-gaap--AcquisitionCosts_pn6n6_c20230101__20230930_zq4qPdrcclYh" title="Acquisition costs, period cost">3</span> million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet. The purchase price has been allocated approximately $<span id="xdx_902_eus-gaap--PaymentsToAcquireProductiveAssets_pn5n6_c20230101__20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zeYCLNCavp57" title="Purchase price, period cost">60.7</span> million to land and $<span id="xdx_900_eus-gaap--PaymentsToAcquireProductiveAssets_pn5n6_c20230101__20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_z3ZUCp8HxCUg" title="Purchase price, period cost">87.4</span> million to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of <span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20230930__srt--RangeAxis__srt--MinimumMember_zcaukj5s5de4" title="Depreciated over a range::XDX::P7Y"><span style="-sec-ix-hidden: xdx2ixbrl0635">7</span></span> to <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20230930__srt--RangeAxis__srt--MaximumMember_zZPkllAEoXR4" title="Depreciated over a range::XDX::P50Y"><span style="-sec-ix-hidden: xdx2ixbrl0637">50</span></span> years. The Company has elected to depreciate the building cost based on the useful lives of its components. Approximately $<span id="xdx_904_eus-gaap--EscrowDeposit_iI_pn5n6_c20230930_zHIcW9FEcf1i" title="Cash held in escrow is included in other assets">1.2</span> million of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of September 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The acquisition was financed by a <span id="xdx_90E_eus-gaap--LongTermDebtTerm_iI_dxL_c20230930_zI9hYHPFONsi" title="Long-term debt, term::XDX::P10Y"><span style="-sec-ix-hidden: xdx2ixbrl0641">10</span></span>-year €<span id="xdx_905_eus-gaap--LineOfCredit_iI_dxL_uUSDEUR_c20230930_zeDFx19IOXo7" title="Long-term line of credit::XDX::120000000"><span style="-sec-ix-hidden: xdx2ixbrl0643">120 million</span></span> (approximately $<span id="xdx_902_eus-gaap--LineOfCredit_iI_dm_c20230930_zhRNtN9gyJu4" title="Long-term line of credit">127.1 million</span>) bank loan which bears interest at <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateTerms_c20230101__20230930_zIEeSIDxYfSl" title="Description of debt instrument interest rate terms">one-month Euribor plus 0.75%</span>. Approximately €<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_dxL_uUSDEUR_c20230930_zoqFdZEaXmu5" title="Debt instrument, face amount::XDX::80000000"><span style="-sec-ix-hidden: xdx2ixbrl0649">80 million</span></span> of the variable rate debt was swapped for variable interest rate debt with a maximum rate of <span id="xdx_90F_eus-gaap--DerivativeVariableInterestRate_iI_pid_dp_uPure_c20230930_zDIF2RsmGRaa" title="Variable interest rate">2</span>% per annum. The swap effectively exchanges the variable interest rate to a fixed rate of approximately <span id="xdx_90D_eus-gaap--DerivativeFixedInterestRate_iI_pid_dp_uPure_c20230930_zQElmcQNKRqh" title="Fixed interest rate">1.1</span>%.</span></p> The license became effective in July 2023 and will last for 6.5 years. The license becomes effective in January 2024 and will last for 15 years. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock to the licensor valued at $5.0 million. The exclusive license became effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024. we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value. 0.72 148100000 3000000 60700000 87400000 1200000 127100000 one-month Euribor plus 0.75% 0.02 0.011 <p id="xdx_801_eus-gaap--NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_zleFFUDjFHX5" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_82D_zlWNoWhmWHW8">Recent Accounting Pronouncements:</span></span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.</span></p> <p id="xdx_80D_eus-gaap--InventoryDisclosureTextBlock_zg6OUAQnJtpk" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.5in; text-align: left"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>5.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_82A_zYBkNkEqwbw2">Inventories:</span></span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zSck83pW3B4b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zJIwvFc3LGSd">Inventories consist of the following:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 87%; margin-left: 0.7in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In thousands)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230930_z2ERd1cXJf5l" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20221231_zXP4PoRisjm6" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--InventoryRawMaterials_iI_pn3n3_uUSD_zSza1ygrahm3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw materials and component parts</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">151,344</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">146,772</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pn3n3_uUSD_zJpKV2ydUYR9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished goods</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">212,926</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">143,212</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--InventoryNet_iTI_pn3n3_zRDiVrOUtvYc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none; visibility: hidden">Inventories</b></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">364,270</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">289,984</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zeEAT2UMmexh" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zSck83pW3B4b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zJIwvFc3LGSd">Inventories consist of the following:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 87%; margin-left: 0.7in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In thousands)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230930_z2ERd1cXJf5l" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20221231_zXP4PoRisjm6" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--InventoryRawMaterials_iI_pn3n3_uUSD_zSza1ygrahm3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw materials and component parts</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">151,344</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">146,772</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pn3n3_uUSD_zJpKV2ydUYR9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished goods</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">212,926</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">143,212</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--InventoryNet_iTI_pn3n3_zRDiVrOUtvYc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none; visibility: hidden">Inventories</b></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">364,270</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">289,984</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 151344000 146772000 212926000 143212000 364270000 289984000 <p id="xdx_804_eus-gaap--FairValueDisclosuresTextBlock_zjo9lLqa8kk1" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_822_zW9lxxgWlDl8">Fair Value Measurement:</span></span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zibCjDpJV6Fk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zE5SDIQK6P19">The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFHlJn2zqnpj" style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td id="xdx_49A_20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zwItEN5uGGz7" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td id="xdx_497_20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8bsdM26s8Nb" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td colspan="2" id="xdx_496_20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8nuGoFUFNme" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value Measurements at September 30, 2023</b></span></td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted Prices in</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Other</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Active Markets for</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identical Assets</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 1)</b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 2)</b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 3)</b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_402_eus-gaap--AssetsFairValueDisclosureAbstract_iB_z1OKK7vStvQh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zCK4O6hqqZX8" style="vertical-align: bottom; background-color: White"> <td style="width: 36%; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term investments</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,745</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,177</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92,776</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">792</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--DerivativeAssets_i01I_zRO63LNJMkR7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest rate swaps</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,274</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0685">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,274</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0687">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AssetsFairValueDisclosure_i01I_zcCa4PMyzV5h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none; visibility: hidden">Total asset</b></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,019</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,177</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99,050</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">792</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_znWkqNQqnS0j" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_z6Ut0j1RVvq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">791</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0700">—</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">791</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0702">—</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_z87LUGE3C81d" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency forward exchange contracts accounted for using hedge accounting</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0705">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0707">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--LiabilitiesFairValueDisclosure_iI_zuZigcQf3VL5" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b style="display: none; visibility: hidden">Total liabilities</b></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,280</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0710">—</span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,280</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0712">—</span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; color: Red"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zpz6rw7U8CTe" style="text-align: center; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td id="xdx_496_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhbk2nrOZHya" style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td id="xdx_49A_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zBeo3L0Pjufc" style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td colspan="3" id="xdx_49C_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zubQ6gI7pnCg" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value Measurements at December 31, 2022</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted Prices in</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Other</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Active Markets for</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identical Assets</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 1)</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 2)</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 3)</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zdTXi4DYFR42" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zh86BHHwHOq" style="vertical-align: bottom; background-color: White"> <td style="width: 36%; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term investments</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,833</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,861</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130,174</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">798</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--DerivativeAssets_iI_zYBTOWAP0YVg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest rate swaps</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,758</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0729">—</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,758</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0731">—</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zqY4gkiIWp9f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency forward exchange contracts accounted for using hedge accounting</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,189</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0734">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,189</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0736">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--AssetsFairValueDisclosure_iI_zOIB4TGbeCrk" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none; visibility: hidden">Total asset</b></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">158,780</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,861</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138,121</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">798</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zcskvuAHsKpa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zAdktey7vrAg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0749">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0751">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zPK0e3rW8XU" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none; visibility: hidden">Total liabilities</b></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0754">—</span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0756">—</span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A8_zIlQ5WY8nKL5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amount of cash and cash equivalents including money market funds, short-term investments, accounts receivable, other receivables, cash held in escrow, accounts payable and accrued expenses approximate fair value due to the short terms to maturity of these instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net present value of the swaps using third party quotes from financial institutions.</span></p> <p id="xdx_894_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zibCjDpJV6Fk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zE5SDIQK6P19">The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFHlJn2zqnpj" style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td id="xdx_49A_20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zwItEN5uGGz7" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td id="xdx_497_20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8bsdM26s8Nb" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td colspan="2" id="xdx_496_20230930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8nuGoFUFNme" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value Measurements at September 30, 2023</b></span></td><td style="text-align: center; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted Prices in</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Other</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Active Markets for</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identical Assets</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td><td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 1)</b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 2)</b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 3)</b></span></td><td style="text-align: right; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_402_eus-gaap--AssetsFairValueDisclosureAbstract_iB_z1OKK7vStvQh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zCK4O6hqqZX8" style="vertical-align: bottom; background-color: White"> <td style="width: 36%; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term investments</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,745</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,177</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92,776</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">792</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--DerivativeAssets_i01I_zRO63LNJMkR7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest rate swaps</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,274</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0685">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,274</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0687">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AssetsFairValueDisclosure_i01I_zcCa4PMyzV5h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none; visibility: hidden">Total asset</b></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,019</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,177</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99,050</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">792</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_znWkqNQqnS0j" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_z6Ut0j1RVvq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">791</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0700">—</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">791</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0702">—</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_z87LUGE3C81d" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency forward exchange contracts accounted for using hedge accounting</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0705">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0707">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--LiabilitiesFairValueDisclosure_iI_zuZigcQf3VL5" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b style="display: none; visibility: hidden">Total liabilities</b></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,280</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0710">—</span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,280</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0712">—</span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; color: Red"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zpz6rw7U8CTe" style="text-align: center; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td id="xdx_496_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhbk2nrOZHya" style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td id="xdx_49A_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zBeo3L0Pjufc" style="border-bottom: Black 1pt solid; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td colspan="3" id="xdx_49C_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zubQ6gI7pnCg" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value Measurements at December 31, 2022</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted Prices in</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Other</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Active Markets for</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identical Assets</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inputs</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 1)</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 2)</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 3)</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zdTXi4DYFR42" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zh86BHHwHOq" style="vertical-align: bottom; background-color: White"> <td style="width: 36%; text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term investments</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,833</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,861</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130,174</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">798</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--DerivativeAssets_iI_zYBTOWAP0YVg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest rate swaps</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,758</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0729">—</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,758</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0731">—</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_zqY4gkiIWp9f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency forward exchange contracts accounted for using hedge accounting</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,189</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0734">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,189</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0736">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--AssetsFairValueDisclosure_iI_zOIB4TGbeCrk" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none; visibility: hidden">Total asset</b></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">158,780</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,861</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138,121</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">798</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zcskvuAHsKpa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zAdktey7vrAg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0749">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0751">—</span></span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zPK0e3rW8XU" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none; visibility: hidden">Total liabilities</b></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0754">—</span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0756">—</span></span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 103745000 10177000 92776000 792000 6274000 6274000 110019000 10177000 99050000 792000 791000 791000 489000 489000 1280000 1280000 150833000 19861000 130174000 798000 6758000 6758000 1189000 1189000 158780000 19861000 138121000 798000 68000 68000 68000 68000 <p id="xdx_807_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zzRLiuOjZ57c" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_820_zrf6pIgd0Gh1">Derivative Financial Instruments:</span></span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a €<span id="xdx_90B_eus-gaap--DerivativeNotionalAmount_iI_pn6n6_uUSDEUR_c20221231__srt--CurrencyAxis__currency--EUR_zJAVAAkfztK2" title="Loan amount">50</span> million (approximately $<span id="xdx_909_eus-gaap--DerivativeNotionalAmount_iI_pn6n6_uUSD_c20221231_zYXweTkSECRl" title="Loan amount">53</span> million) <span id="xdx_90D_eus-gaap--LongTermDebtTerm_iI_dxL_c20221231_zW51z8vxW4O2" title="Long-term debt, term::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0769">4</span></span>-year term loan with a variable interest rate. This variable rate debt was swapped for variable interest rate debt with a maximum rate of <span id="xdx_90F_eus-gaap--DerivativeSwaptionInterestRate_iI_dp_c20221231_zfLs7pL8XHv3" title="Derivative swap interest rate">2</span>% per annum. This swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the April 2021 acquisition of the office building complex in Paris, €<span id="xdx_904_eus-gaap--DerivativeNotionalAmount_iI_pn6n6_uUSDEUR_c20210430__srt--CurrencyAxis__currency--EUR_zEN9lkbaxHn5" title="Loan amount">120</span> million (approximately $<span id="xdx_901_eus-gaap--DerivativeNotionalAmount_iI_pn5n6_c20210430_zyIBEobJKcrl" title="Loan amount">127.1</span> million) of the purchase price was financed through a <span id="xdx_902_eus-gaap--LongTermDebtTerm_iI_dxL_c20210430_zD0b4LZ4895c" title="Long-term debt, term::XDX::P10Y"><span style="-sec-ix-hidden: xdx2ixbrl0777">10</span></span>-year term loan. The Company entered into interest rate swap contracts related to €<span id="xdx_90D_eus-gaap--DerivativeNotionalAmount_iI_pn6n6_uUSDEUR_c20210430__srt--CurrencyAxis__currency--EUR__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--InterestRateSwapMember_zz90XY32wKc9" title="Loan amount">80</span> million of the loan, effectively exchanging the variable interest rate to a fixed rate of approximately <span id="xdx_90F_eus-gaap--DerivativeSwaptionInterestRate_iI_pid_dp_uPure_c20210430_zYuZ5b7ESfX6" title="Derivative swap interest rate">1.1</span>%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial for the three and nine months ended September 30, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swaps is included in other assets on the accompanying balance sheets. The valuation of foreign currency forward exchange contracts at September 30, 2023 resulted in a net asset and is included in other current assets on the accompanying balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At September 30, 2023, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $<span id="xdx_90D_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_pn6n6_c20230930__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zTD1a8cPACyh" title="Forward exchange contracts">58.0</span> million and GB £<span id="xdx_90B_eus-gaap--DerivativeNotionalAmount_iI_pn6n6_uUSDGBP_c20230930__srt--CurrencyAxis__currency--GBP__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zb1VS52etNJk" title="Loan amount">2.0</span> million which all have maturities of less than <span id="xdx_90F_eus-gaap--MaximumRemainingMaturityOfForeignCurrencyDerivatives1_dxL_c20230101__20230930__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zWMbnXxie2Ag" title="Maturity of foreign currency::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl0787">one</span></span> year.</span></p> 50000000 53000000 0.02 120000000 127100000 80000000 0.011 58000000.0 2000000.0 <p id="xdx_805_eus-gaap--LesseeOperatingLeasesTextBlock_zdQik5njuyKa" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in; text-align: justify"></td><td style="width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_825_zsJ1jKaDl0Ee">Leases:</span></span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the weighted average remaining lease term was <span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dxL_c20230930_zKug5z0gIxh" title="Operating lease, weighted average remaining lease term::XDX::P5Y4M24D"><span style="-sec-ix-hidden: xdx2ixbrl0796">5.4</span></span> years and the weighted average discount rate used to determine the operating lease liability was <span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230930_zvJkmE4YnOe3" title="Operating lease, weighted average discount rate, percent">3.0</span>%. Rental expense related to operating leases was $<span id="xdx_900_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dm_c20230701__20230930_z9yZaMSS91Hi" title="Operating leases, rent expense, net">1.5 million</span> and $<span id="xdx_901_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dm_c20230101__20230930_z61LUM4OEnMa" title="Operating leases, rent expense, net">4.5 million</span> for the three and nine months ended September 30, 2023, respectively, as compared to $<span id="xdx_90D_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pn5n6_c20220701__20220930_z6BxMSWDHT26" title="Operating leases, rent expense, net">1.2</span> million and $<span id="xdx_906_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pn5n6_c20220101__20220930_zHuxml5OWWm4" title="Operating leases, rent expense, net">4.3</span> million for the corresponding periods of the prior year. Operating lease payments included in operating cash flows totaled $<span id="xdx_900_eus-gaap--OperatingLeasePayments_dxL_uUSD_c20230101__20230930_zf8hNN3LDGSg" title="Operating lease, payments::XDX::4000000"><span style="-sec-ix-hidden: xdx2ixbrl0808">4.0</span></span> million and $<span id="xdx_904_eus-gaap--OperatingLeasePayments_dm_c20220101__20220930_z9HLVD6aaom1" title="Operating lease, payments">3.9 million</span> for the nine months ended September 30, 2023 and 2022, respectively, and noncash additions to operating lease assets totaled $<span id="xdx_904_eus-gaap--OperatingLeaseCost_pn5n6_c20230101__20230930_zABkJQpTm7Vf" title="Noncash additions to operating lease assets">5.7</span> million and $<span id="xdx_901_eus-gaap--OperatingLeaseCost_pn5n6_c20220101__20220930_zfFyyKE9Bqoe" title="Noncash additions to operating lease assets">0.5</span> million for the nine months ended September 30, 2023 and 2022, respectively.</span></p> 0.030 1500000 4500000 1200000 4300000 3900000 5700000 500000 <p id="xdx_80D_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zmSiEzPCCl77" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in; text-align: justify"></td><td style="width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_82B_ziO383PCmyk5">Share-Based Payments:</span></span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20230101__20230930__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_z2AqYCdbgWbb" title="Options vesting period::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0818">four</span></span> to <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20230101__20230930__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_z6rOUNmwkLbd" title="Options vesting period::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0820">five</span></span>-year period. The fair value of shares vested during the nine months ended September 30, 2023 and 2022 aggregated $<span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20230101__20230930__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3K7I9Osohh" title="Fair value of shares vested">0.10 million</span> and $<span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_dm_c20220101__20220930__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z3t7dyJsQF1g" title="Fair value of shares vested">0.11 million</span>, respectively. Compensation cost, net of forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zLa2jrMpkrq8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zgVVpkhmJTSi">The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.7in"> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></p></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant-Date</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></p></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested options – beginning of period</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20230101__20230930_z7ApouitwXs6" style="width: 10%; text-align: right" title="Nonvested options beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">168,730</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230930_zrvi8ufdZm0h" style="width: 10%; text-align: right" title="Weighted average grant date fair value, beginning of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.31</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested options granted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230101__20230930_zf0svS0tIe89" style="text-align: right" title="Nonvested options granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0832">—</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230930_zOv2zdwBhTmh" style="text-align: right" title="Weighted average grant date fair value, nonvested options granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0834">—</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested options vested or forfeited</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20230101__20230930_zmD552pZdf8e" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(27,625</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20230101__20230930_zRnDmVz9wZF1" style="text-align: right" title="Weighted average grant date fair value, nonvested options vested or forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.91</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested options – end of period</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20230101__20230930_zWlsmEwT5Qd6" style="border-bottom: Black 2.5pt double; text-align: right" title="Nonvested options end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,105</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230930_znxKIFGDDPwe" style="text-align: right" title="Weighted average grant date fair value, nonvested options end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.78</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zH4QEB5U3Wc7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based payment expense decreased income before income taxes by $<span id="xdx_905_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_pn3n3_dxL_c20230701__20230930_zIToPuXWoLC5" title="Income before income taxes::XDX::86613"><span style="-sec-ix-hidden: xdx2ixbrl0844">0.62</span></span> million and $<span id="xdx_90F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_pn3n3_dxL_c20230101__20230930_zBhZ0Fw3UaA2" title="::XDX::234674"><span style="-sec-ix-hidden: xdx2ixbrl0845">1.89</span></span> million for the three and nine months ended September 30, 2023, respectively, as compared to $<span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_pn3n3_dxL_c20230701__20230930_zVkdooP4uXP7" title="::XDX::86613"><span style="-sec-ix-hidden: xdx2ixbrl0846">0.47</span></span> million and $<span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_pn3n3_dxL_c20230101__20230930_zdkj6OfaUbG1" title="::XDX::234674"><span style="-sec-ix-hidden: xdx2ixbrl0847">2.35</span></span> million for the corresponding periods of the prior year. Share-based payment expense decreased income attributable to Inter Parfums, Inc. by $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_dm_c20230701__20230930_zxTI5baq5U6c" title="Share-based payment arrangement, expense">0.41 million</span> and $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_dm_c20230101__20230930_zzsK8jery6c1" title="Share-based payment arrangement, expense">1.27 million</span> for the three and nine months ended September 30, 2023, respectively, as compared to $<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_dm_c20220701__20220930_z4STLT0ptxw8" title="Share-based payment arrangement, expense">0.34 million</span> and $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_dm_c20220101__20220930_z4LsZxSTDm24" title="Share-based payment arrangement, expense">1.52 million</span> for the corresponding periods of the prior year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ze4My13u5qk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zxnbfzAY9dla">The following table summarizes stock option information as of September 30, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.7in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 59%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at January 1, 2023</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230101__20230930_zFnNM3jt0FU6" style="width: 10%; text-align: right" title="Options shares under option - beginning of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">441,580</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230930_zhbiNMq8ewrd" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67.30</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230101__20230930_zHxd02pIibM4" style="text-align: right" title="Options forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230930_zoFPIHivXd98" style="text-align: right" title="Weighted average exercise price options forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72.22</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options exercised</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230101__20230930_zP5wYQoG22ri" style="border-bottom: Black 1pt solid; text-align: right" title="Options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(98,565</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230930_zN8Q7qkJdlM3" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56.03</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at September 30, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20230101__20230930_z3Cna0QOa3X4" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">322,990</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230930_zO1uv3qVrXYc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price shares under option - end of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.43</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options exercisable</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_uShares_c20230930_z908vOAHw0b2" style="text-align: right" title="Options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">181,885</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20230930_zO7PqpkGV7Z8" style="text-align: right" title="Weighted average exercise price options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61.44</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options available for future grants</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_uShares_c20230930_zIsgYmUlHtE8" style="text-align: right" title="Options available for future grants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">579,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A8_zcxNoGDH83oe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the weighted average remaining contractual life of options outstanding is <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxL_c20230101__20230930_ztiCx2SPMn3k" title="Weighted average remaining contractual life of options outstanding (in years)::XDX::P2Y1M24D"><span style="-sec-ix-hidden: xdx2ixbrl0886">2.15</span></span> years (<span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dxL_c20230101__20230930_z0ghgvi0n2V2" title="Weighted average remaining contractual life of options exercisable (in years)::XDX::P0Y4M2D"><span style="-sec-ix-hidden: xdx2ixbrl0888">0.34</span></span> years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_dm_c20230930_zokTNyaZTw2" title="Aggregate intrinsic value of options outstanding and options outstanding">20.64 million</span> and $<span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_dm_c20230930_zaeNsLvF4C83" title="Aggregate intrinsic value of options outstanding and options exercisable">13.26 million</span>, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $<span id="xdx_90D_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pn5n6_c20230930_zeMW2B8bQ4wh" title="Unrecognized compensation cost">1.7</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_z9EIWCL5wBH5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zUHqbSW3OmAh">Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 87%; margin-left: 0.7in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In thousands)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,  <br/>2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,  <br/>2022</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash proceeds from stock options exercised</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--ProceedsFromSaleAndCollectionOfReceivables_pn3n3_c20230101__20230930_zQxApUVWAQj" style="width: 10%; text-align: right" title="Cash proceeds from stock options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,523</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--ProceedsFromSaleAndCollectionOfReceivables_pn3n3_c20220101__20220930_z8bHchdd98Bb" style="width: 10%; text-align: right" title="Cash proceeds from stock options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,816</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax benefits</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_pn3n3_c20230101__20230930_zAckpzr3BW5h" style="text-align: right" title="Tax benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_pn3n3_c20220101__20220930_zDgC3xaZK2" style="text-align: right" title="Tax benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">320</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic value of stock options exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pn3n3_c20230101__20230930_z1Du5k00LCi3" style="text-align: right" title="Intrinsic value of stock options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,135</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pn3n3_c20220101__20220930_zZgYUDpEMWY3" style="text-align: right" title="Intrinsic value of stock options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,105</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zOUiAunlT314" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_do_uShares_c20230101__20230930_zeIISmleyfhe" title="Options granted"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_do_uShares_c20220101__20220930_zPbLORdOQJk8" title="Options granted">no</span></span> options granted during the nine months ended September 30, 2023 and September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would increase as the earnings of the Company and its stock price continues to increase.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2018, Interparfums SA approved a plan to grant an aggregate of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zMGPRDTPcNg2" title="Aggregate shares to offices and manager">26,600</span> shares of its stock to employees with no performance condition requirement, and an aggregate of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--OfficersAndManagersMember_z9FjpnH3mRbj" title="Aggregate shares to offices and managers">133,000</span> shares to officers and managers, subject to certain corporate performance conditions. The corporate performance conditions were met and therefore in June 2022, <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesStockSplits_pid_uShares_c20220601__20220630_z9JCgj5Jzzvl" title="Adjusted for stock splits">211,955</span> shares, adjusted for stock splits, were distributed. The aggregate cost of the grant of approximately $<span id="xdx_900_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_pn5n6_c20220601__20220630_zDtlZ3A0BLxi" title="Recognized as compensation cost">4.8</span> million was recognized as compensation cost on a straight-line basis over the requisite three-year service period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2022, Interparfums SA approved an additional plan to grant an aggregate of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20220331__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zhCPKatzeJ6e">88,400</span> shares to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the NYSE Euronext on the date of grant. The estimated number of shares to be distributed of <span id="xdx_90D_eus-gaap--DistributionMadeToLimitedPartnerUnitDistribution_pid_uShares_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zQXDnV8y7M1e" title="Number of share distributed">92,998</span> has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $<span id="xdx_90A_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_dm_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember_zEJK2CzFtFz">4.2 million</span> will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Similar to the December 2018 plan, in order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. As of September 30, 2023 the Company acquired <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20230930__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zYiIuVz81iij">87,609</span> shares at an aggregate cost of $<span id="xdx_90F_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_dm_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zaV4a1BwrRsh">4.1 million</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All share purchases and issuances have been classified as equity transactions on the accompanying balance sheet.</span></p> 100000 110000 <p id="xdx_890_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zLa2jrMpkrq8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zgVVpkhmJTSi">The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.7in"> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></p></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant-Date</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></p></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested options – beginning of period</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20230101__20230930_z7ApouitwXs6" style="width: 10%; text-align: right" title="Nonvested options beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">168,730</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230930_zrvi8ufdZm0h" style="width: 10%; text-align: right" title="Weighted average grant date fair value, beginning of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.31</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested options granted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230101__20230930_zf0svS0tIe89" style="text-align: right" title="Nonvested options granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0832">—</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230930_zOv2zdwBhTmh" style="text-align: right" title="Weighted average grant date fair value, nonvested options granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0834">—</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested options vested or forfeited</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20230101__20230930_zmD552pZdf8e" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(27,625</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20230101__20230930_zRnDmVz9wZF1" style="text-align: right" title="Weighted average grant date fair value, nonvested options vested or forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.91</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested options – end of period</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20230101__20230930_zWlsmEwT5Qd6" style="border-bottom: Black 2.5pt double; text-align: right" title="Nonvested options end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,105</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230930_znxKIFGDDPwe" style="text-align: right" title="Weighted average grant date fair value, nonvested options end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.78</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 168730 16.31 27625 13.91 141105 16.78 410000 1270000 340000 1520000 <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ze4My13u5qk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zxnbfzAY9dla">The following table summarizes stock option information as of September 30, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.7in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 59%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at January 1, 2023</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230101__20230930_zFnNM3jt0FU6" style="width: 10%; text-align: right" title="Options shares under option - beginning of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">441,580</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230930_zhbiNMq8ewrd" style="width: 10%; text-align: right" title="Weighted average exercise price shares under option - beginning of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67.30</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230101__20230930_zHxd02pIibM4" style="text-align: right" title="Options forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230930_zoFPIHivXd98" style="text-align: right" title="Weighted average exercise price options forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72.22</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options exercised</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230101__20230930_zP5wYQoG22ri" style="border-bottom: Black 1pt solid; text-align: right" title="Options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(98,565</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230930_zN8Q7qkJdlM3" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56.03</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at September 30, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20230101__20230930_z3Cna0QOa3X4" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">322,990</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230930_zO1uv3qVrXYc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price shares under option - end of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.43</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options exercisable</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_uShares_c20230930_z908vOAHw0b2" style="text-align: right" title="Options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">181,885</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20230930_zO7PqpkGV7Z8" style="text-align: right" title="Weighted average exercise price options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61.44</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options available for future grants</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_uShares_c20230930_zIsgYmUlHtE8" style="text-align: right" title="Options available for future grants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">579,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 441580 67.30 20025 72.22 98565 56.03 322990 70.43 181885 61.44 579000 20640000 13260000 1700000 <p id="xdx_895_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_z9EIWCL5wBH5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zUHqbSW3OmAh">Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 87%; margin-left: 0.7in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In thousands)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,  <br/>2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,  <br/>2022</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash proceeds from stock options exercised</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--ProceedsFromSaleAndCollectionOfReceivables_pn3n3_c20230101__20230930_zQxApUVWAQj" style="width: 10%; text-align: right" title="Cash proceeds from stock options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,523</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--ProceedsFromSaleAndCollectionOfReceivables_pn3n3_c20220101__20220930_z8bHchdd98Bb" style="width: 10%; text-align: right" title="Cash proceeds from stock options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,816</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax benefits</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_pn3n3_c20230101__20230930_zAckpzr3BW5h" style="text-align: right" title="Tax benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_pn3n3_c20220101__20220930_zDgC3xaZK2" style="text-align: right" title="Tax benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">320</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic value of stock options exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pn3n3_c20230101__20230930_z1Du5k00LCi3" style="text-align: right" title="Intrinsic value of stock options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,135</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pn3n3_c20220101__20220930_zZgYUDpEMWY3" style="text-align: right" title="Intrinsic value of stock options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,105</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 5523000 1816000 900000 320000 6135000 2105000 0 0 26600 133000 211955 4800000 88400 92998 4200000 87609 4100000 <p id="xdx_804_eus-gaap--EarningsPerShareTextBlock_zgzQVr7BZiDe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_826_z98iuPUlbeEe">Net Income Attributable to Inter Parfums, Inc. Common Shareholders:</span></span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z5ZqIOJ2MY" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zy0galU2uCk9">The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; color: Red"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: center"> </td> <td id="xdx_49E_20230701__20230930_zGAlZXYQTbxh" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td id="xdx_494_20220701__20220930_zp9GMhrd1zD" style="text-align: center"> </td><td> </td><td> </td> <td style="text-align: center"> </td> <td id="xdx_49C_20230101__20230930_zUTRLzMtRKk3" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td id="xdx_491_20220101__20220930_zyFiRW7y8JB5" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three months ended</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine months ended</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In thousands)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_iB_zN6TCMAQoSkd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 50%; text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income attributable to Inter Parfums, Inc.</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20230701__20230930_zrv91yZcuhDb" style="border-bottom: Black 2.5pt double; width: 8%; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,214</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_c20220701__20220930_zcneuVLZk4xa" style="border-bottom: Black 2.5pt double; width: 8%; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,423</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20230101__20230930_ztsLnGzod0O9" style="border-bottom: Black 2.5pt double; width: 8%; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142,234</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20220101__20220930_zS5LaMGqwPk3" style="border-bottom: Black 2.5pt double; width: 8%; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104,339</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_zDsGbawwj586" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_uShares_madpes_zQbknXko50Wc" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average shares</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,976</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,860</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,848</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of dilutive securities:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pid_uShares_madpes_zEY9yvHJ1ixb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">148</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">149</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">129</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--ProFormaWeightedAverageSharesOutstandingDiluted_i01_pid_uShares_mtdpes_zAtntZgbWsii" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.5in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,124</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,968</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,149</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,977</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings per share:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB_z9ZvwlNU3Ej4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income attributable to Inter</span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parfums, Inc. common shareholders:</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr id="xdx_407_eus-gaap--EarningsPerShareBasic_i01_pid_uUSDPShares_z3FuGclJufhi" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.66</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.30</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.44</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.28</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--EarningsPerShareDiluted_i01_pid_uUSDPShares_z12cA6Ivhbd5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.66</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.30</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.42</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.26</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; color: Red"></p> <p id="xdx_8A6_z5CiFkK5waJ7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were <span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_uShares_c20230701__20230930_zJEVwOeFEFRf" title="Antidilutive potential common shares outstanding"><span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_uShares_c20230101__20230930_zq5pE7kkZxWg" title="Antidilutive potential common shares outstanding">no</span></span> antidilutive potential common shares outstanding for the three and nine months ended September 30, 2023. Not included in the above computations are the effect of antidilutive potential common shares which consist of outstanding options to purchase <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dm_uShares_c20220701__20220930_z9x7zgMnt4nf" title="Antidilutive potential common shares outstanding"><span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dm_uShares_c20220101__20220930_zYQUco8TW0pa" title="Antidilutive potential common shares outstanding">0.15 million</span></span> shares of common stock for both the three and nine months ended September 30, 2022, respectively.</span></p> <p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z5ZqIOJ2MY" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zy0galU2uCk9">The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; color: Red"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: center"> </td> <td id="xdx_49E_20230701__20230930_zGAlZXYQTbxh" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td id="xdx_494_20220701__20220930_zp9GMhrd1zD" style="text-align: center"> </td><td> </td><td> </td> <td style="text-align: center"> </td> <td id="xdx_49C_20230101__20230930_zUTRLzMtRKk3" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td id="xdx_491_20220101__20220930_zyFiRW7y8JB5" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three months ended</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine months ended</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In thousands)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_iB_zN6TCMAQoSkd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 50%; text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income attributable to Inter Parfums, Inc.</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20230701__20230930_zrv91yZcuhDb" style="border-bottom: Black 2.5pt double; width: 8%; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,214</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_c20220701__20220930_zcneuVLZk4xa" style="border-bottom: Black 2.5pt double; width: 8%; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,423</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20230101__20230930_ztsLnGzod0O9" style="border-bottom: Black 2.5pt double; width: 8%; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142,234</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20220101__20220930_zS5LaMGqwPk3" style="border-bottom: Black 2.5pt double; width: 8%; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104,339</span></td><td style="width: 1%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_zDsGbawwj586" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_uShares_madpes_zQbknXko50Wc" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average shares</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,976</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,860</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,848</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of dilutive securities:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pid_uShares_madpes_zEY9yvHJ1ixb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">148</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">149</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">129</span></td><td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--ProFormaWeightedAverageSharesOutstandingDiluted_i01_pid_uShares_mtdpes_zAtntZgbWsii" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.5in; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,124</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,968</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,149</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,977</span></td><td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings per share:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB_z9ZvwlNU3Ej4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income attributable to Inter</span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parfums, Inc. common shareholders:</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr id="xdx_407_eus-gaap--EarningsPerShareBasic_i01_pid_uUSDPShares_z3FuGclJufhi" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.66</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.30</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.44</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.28</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--EarningsPerShareDiluted_i01_pid_uUSDPShares_z12cA6Ivhbd5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.66</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.30</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.42</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.26</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; color: Red"></p> 53214000 41423000 142234000 104339000 31976 31860 32000 31848 148 108 149 129 32124 31968 32149 31977 1.66 1.30 4.44 3.28 1.66 1.30 4.42 3.26 0 0 150000 150000 <p id="xdx_805_eus-gaap--SegmentReportingDisclosureTextBlock_zZNF6u039blg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_823_zhrafhtBoKii">Segment and Geographic Areas:</span></span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European operations and United States operations primarily represent the sale of prestige brand name fragrances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z8EZtIj1WGRc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z33hh3sxpXf6">Information on our operations by geographical areas is as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.7in"> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In thousands)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three months ended<br/> September 30,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine months ended<br/> September 30,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net sales:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 38%; text-align: justify; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230701__20230930__srt--StatementGeographicalAxis__country--US_zcpJ4uQrTcSa" style="width: 10%; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">134,469</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220701__20220930__srt--StatementGeographicalAxis__country--US_zOI8UhqSTy8l" style="width: 10%; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,183</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230930__srt--StatementGeographicalAxis__country--US_zhlLUVbULP41" style="width: 10%; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">327,359</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220930__srt--StatementGeographicalAxis__country--US_zeINveRmM5t3" style="width: 10%; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">229,129</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Europe</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230701__20230930__srt--StatementGeographicalAxis__srt--EuropeMember_zzBUMUyBU49l" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">233,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220701__20220930__srt--StatementGeographicalAxis__srt--EuropeMember_zfdfcJP0Es7k" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">198,318</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230930__srt--StatementGeographicalAxis__srt--EuropeMember_ziX4WZHfbUea" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">661,577</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220930__srt--StatementGeographicalAxis__srt--EuropeMember_zcCdy1z64gz6" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">546,787</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eliminations</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230701__20230930__srt--StatementGeographicalAxis__custom--EliminationsMember_zyctninTmOGc" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1008">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220701__20220930__srt--StatementGeographicalAxis__custom--EliminationsMember_zj5fHw76xeJi" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230930__srt--StatementGeographicalAxis__custom--EliminationsMember_zLxNkqWzB9Bf" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1012">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220930__srt--StatementGeographicalAxis__custom--EliminationsMember_zDCvsOSauV54" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(51</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230701__20230930_z1Tqa9enflKe" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">367,969</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220701__20220930_z79jo1qlMvo4" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280,462</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230930_zoSBQRt4sx83" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">988,936</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220930_zWxhYUIdrtk4" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">775,865</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income attributable to Inter Parfums, Inc.:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20230930__srt--StatementGeographicalAxis__country--US_zDabIERrY90b" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,157</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20220930__srt--StatementGeographicalAxis__country--US_zFBtKHyeeZHd" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,881</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230930__srt--StatementGeographicalAxis__country--US_zKj3WKLd3DA1" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,067</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220930__srt--StatementGeographicalAxis__country--US_zgG06x3jCCI" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,386</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Europe</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20230930__srt--StatementGeographicalAxis__srt--EuropeMember_zHzgGUb28vv7" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,057</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20220930__srt--StatementGeographicalAxis__srt--EuropeMember_zS1dqo9TUFB8" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,542</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230930__srt--StatementGeographicalAxis__srt--EuropeMember_zET0usodH2wb" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,167</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220930__srt--StatementGeographicalAxis__srt--EuropeMember_zPMi6XkVWcmi" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76,953</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20230930_zlLopac0FtOf" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,214</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20220930_zhmPNSVDb0s7" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc."> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,423</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230930_zaNsdBzVmVWa" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142,234</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220930_z08DBZkFJclb" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104,339</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20230930__srt--StatementGeographicalAxis__country--US_z6sZsNkrrFSd" style="text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">340,375</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__country--US_zeou92Hhv6Ac" style="text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">278,090</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Europe</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20230930__srt--StatementGeographicalAxis__srt--EuropeMember_zc6JgN2RYYWh" style="text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,083,843</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_z3dTvn0pzi5c" style="text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,052,004</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eliminations</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20230930__srt--StatementGeographicalAxis__custom--EliminationsMember_zkwOixAVWPI7" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,821</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zxGl1LS9b8w4" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,552</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--Assets_iI_pn3n3_c20230930_zIndY34N8Vic" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,394,397</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20221231_zy1WttsZSPBb" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,308,542</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_zkiwYR7h7oOh" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z8EZtIj1WGRc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z33hh3sxpXf6">Information on our operations by geographical areas is as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.7in"> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In thousands)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three months ended<br/> September 30,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine months ended<br/> September 30,</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net sales:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 38%; text-align: justify; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230701__20230930__srt--StatementGeographicalAxis__country--US_zcpJ4uQrTcSa" style="width: 10%; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">134,469</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220701__20220930__srt--StatementGeographicalAxis__country--US_zOI8UhqSTy8l" style="width: 10%; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,183</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230930__srt--StatementGeographicalAxis__country--US_zhlLUVbULP41" style="width: 10%; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">327,359</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220930__srt--StatementGeographicalAxis__country--US_zeINveRmM5t3" style="width: 10%; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">229,129</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Europe</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230701__20230930__srt--StatementGeographicalAxis__srt--EuropeMember_zzBUMUyBU49l" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">233,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220701__20220930__srt--StatementGeographicalAxis__srt--EuropeMember_zfdfcJP0Es7k" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">198,318</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230930__srt--StatementGeographicalAxis__srt--EuropeMember_ziX4WZHfbUea" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">661,577</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220930__srt--StatementGeographicalAxis__srt--EuropeMember_zcCdy1z64gz6" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">546,787</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eliminations</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230701__20230930__srt--StatementGeographicalAxis__custom--EliminationsMember_zyctninTmOGc" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1008">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220701__20220930__srt--StatementGeographicalAxis__custom--EliminationsMember_zj5fHw76xeJi" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230930__srt--StatementGeographicalAxis__custom--EliminationsMember_zLxNkqWzB9Bf" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1012">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220930__srt--StatementGeographicalAxis__custom--EliminationsMember_zDCvsOSauV54" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(51</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230701__20230930_z1Tqa9enflKe" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">367,969</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220701__20220930_z79jo1qlMvo4" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280,462</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230930_zoSBQRt4sx83" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">988,936</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220930_zWxhYUIdrtk4" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">775,865</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income attributable to Inter Parfums, Inc.:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20230930__srt--StatementGeographicalAxis__country--US_zDabIERrY90b" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,157</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20220930__srt--StatementGeographicalAxis__country--US_zFBtKHyeeZHd" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,881</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230930__srt--StatementGeographicalAxis__country--US_zKj3WKLd3DA1" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,067</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220930__srt--StatementGeographicalAxis__country--US_zgG06x3jCCI" style="text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,386</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Europe</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20230930__srt--StatementGeographicalAxis__srt--EuropeMember_zHzgGUb28vv7" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,057</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20220930__srt--StatementGeographicalAxis__srt--EuropeMember_zS1dqo9TUFB8" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,542</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230930__srt--StatementGeographicalAxis__srt--EuropeMember_zET0usodH2wb" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,167</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220930__srt--StatementGeographicalAxis__srt--EuropeMember_zPMi6XkVWcmi" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76,953</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20230930_zlLopac0FtOf" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,214</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20220930_zhmPNSVDb0s7" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc."> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,423</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230930_zaNsdBzVmVWa" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142,234</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220930_z08DBZkFJclb" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104,339</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20230930__srt--StatementGeographicalAxis__country--US_z6sZsNkrrFSd" style="text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">340,375</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__country--US_zeou92Hhv6Ac" style="text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">278,090</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Europe</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20230930__srt--StatementGeographicalAxis__srt--EuropeMember_zc6JgN2RYYWh" style="text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,083,843</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_z3dTvn0pzi5c" style="text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,052,004</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eliminations</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20230930__srt--StatementGeographicalAxis__custom--EliminationsMember_zkwOixAVWPI7" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,821</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zxGl1LS9b8w4" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,552</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--Assets_iI_pn3n3_c20230930_zIndY34N8Vic" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,394,397</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20221231_zy1WttsZSPBb" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,308,542</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 134469000 82183000 327359000 229129000 233500000 198318000 661577000 546787000 -39000 -51000 367969000 280462000 988936000 775865000 20157000 10881000 46067000 27386000 33057000 30542000 96167000 76953000 53214000 41423000 142234000 104339000 340375000 278090000 1083843000 1052004000 -29821000 -21552000 1394397000 1308542000 EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 98 219 1 false 30 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://interparfumsinc.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome CONSOLIDATED STATEMENTS OF INCOME (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 7 false false R8.htm 00000008 - Disclosure - Significant Accounting Policies: Sheet http://interparfumsinc.com/role/SignificantAccountingPolicies Significant Accounting Policies: Notes 8 false false R9.htm 00000009 - Disclosure - Impact of COVID-19 Pandemic: Sheet http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic Impact of COVID-19 Pandemic: Notes 9 false false R10.htm 00000010 - Disclosure - Recent Agreements: Sheet http://interparfumsinc.com/role/RecentAgreements Recent Agreements: Notes 10 false false R11.htm 00000011 - Disclosure - Recent Accounting Pronouncements: Sheet http://interparfumsinc.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements: Notes 11 false false R12.htm 00000012 - Disclosure - Inventories: Sheet http://interparfumsinc.com/role/Inventories Inventories: Notes 12 false false R13.htm 00000013 - Disclosure - Fair Value Measurement: Sheet http://interparfumsinc.com/role/FairValueMeasurement Fair Value Measurement: Notes 13 false false R14.htm 00000014 - Disclosure - Derivative Financial Instruments: Sheet http://interparfumsinc.com/role/DerivativeFinancialInstruments Derivative Financial Instruments: Notes 14 false false R15.htm 00000015 - Disclosure - Leases: Sheet http://interparfumsinc.com/role/Leases Leases: Notes 15 false false R16.htm 00000016 - Disclosure - Share-Based Payments: Sheet http://interparfumsinc.com/role/Share-basedPayments Share-Based Payments: Notes 16 false false R17.htm 00000017 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders Net Income Attributable to Inter Parfums, Inc. Common Shareholders: Notes 17 false false R18.htm 00000018 - Disclosure - Segment and Geographic Areas: Sheet http://interparfumsinc.com/role/SegmentAndGeographicAreas Segment and Geographic Areas: Notes 18 false false R19.htm 00000019 - Disclosure - Inventories: (Tables) Sheet http://interparfumsinc.com/role/InventoriesTables Inventories: (Tables) Tables http://interparfumsinc.com/role/Inventories 19 false false R20.htm 00000020 - Disclosure - Fair Value Measurement: (Tables) Sheet http://interparfumsinc.com/role/FairValueMeasurementTables Fair Value Measurement: (Tables) Tables http://interparfumsinc.com/role/FairValueMeasurement 20 false false R21.htm 00000021 - Disclosure - Share-Based Payments: (Tables) Sheet http://interparfumsinc.com/role/Share-basedPaymentsTables Share-Based Payments: (Tables) Tables http://interparfumsinc.com/role/Share-basedPayments 21 false false R22.htm 00000022 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables) Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables) Tables http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders 22 false false R23.htm 00000023 - Disclosure - Segment and Geographic Areas: (Tables) Sheet http://interparfumsinc.com/role/SegmentAndGeographicAreasTables Segment and Geographic Areas: (Tables) Tables http://interparfumsinc.com/role/SegmentAndGeographicAreas 23 false false R24.htm 00000024 - Disclosure - Recent Agreements: (Details Narrative) Sheet http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative Recent Agreements: (Details Narrative) Details http://interparfumsinc.com/role/RecentAgreements 24 false false R25.htm 00000025 - Disclosure - Inventories consist of the following: (Details) Sheet http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails Inventories consist of the following: (Details) Details 25 false false R26.htm 00000026 - Disclosure - The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details) Sheet http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details) Details 26 false false R27.htm 00000027 - Disclosure - Derivative Financial Instruments: (Details Narrative) Sheet http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative Derivative Financial Instruments: (Details Narrative) Details http://interparfumsinc.com/role/DerivativeFinancialInstruments 27 false false R28.htm 00000028 - Disclosure - Leases: (Details Narrative) Sheet http://interparfumsinc.com/role/LeasesDetailsNarrative Leases: (Details Narrative) Details http://interparfumsinc.com/role/Leases 28 false false R29.htm 00000029 - Disclosure - The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023: (Details) Sheet http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForNineMonthsEndedSeptember302023Details The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023: (Details) Details 29 false false R30.htm 00000030 - Disclosure - The following table summarizes stock option information as of September 30, 2023: (Details) Sheet http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfSeptember302023Details The following table summarizes stock option information as of September 30, 2023: (Details) Details 30 false false R31.htm 00000031 - Disclosure - Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows: (Details) Sheet http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringNineMonthsEndedSeptember302023And2022WereAsFollowsDetails Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows: (Details) Details 31 false false R32.htm 00000032 - Disclosure - Share-Based Payments: (Details Narrative) Sheet http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative Share-Based Payments: (Details Narrative) Details http://interparfumsinc.com/role/Share-basedPaymentsTables 32 false false R33.htm 00000033 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) Sheet http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) Details 33 false false R34.htm 00000034 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative) Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative) Details http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables 34 false false R35.htm 00000035 - Disclosure - Information on our operations by geographical areas is as follows: (Details) Sheet http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails Information on our operations by geographical areas is as follows: (Details) Details 35 false false All Reports Book All Reports g083828_10q.htm ipar-20230930.xsd ipar-20230930_cal.xml ipar-20230930_def.xml ipar-20230930_lab.xml ipar-20230930_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 53 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "g083828_10q.htm": { "nsprefix": "ipar", "nsuri": "http://interparfumsinc.com/20230930", "dts": { "inline": { "local": [ "g083828_10q.htm" ] }, "schema": { "local": [ "ipar-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "ipar-20230930_cal.xml" ] }, "definitionLink": { "local": [ "ipar-20230930_def.xml" ] }, "labelLink": { "local": [ "ipar-20230930_lab.xml" ] }, "presentationLink": { "local": [ "ipar-20230930_pre.xml" ] } }, "keyStandard": 218, "keyCustom": 1, "axisStandard": 12, "axisCustom": 0, "memberStandard": 21, "memberCustom": 9, "hidden": { "total": 57, "http://xbrl.sec.gov/dei/2023": 6, "http://fasb.org/us-gaap/2023": 50, "http://interparfumsinc.com/20230930": 1 }, "contextCount": 98, "entityCount": 1, "segmentCount": 30, "elementCount": 351, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 564, "http://xbrl.sec.gov/dei/2023": 29 }, "report": { "R1": { "role": "http://interparfumsinc.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R2": { "role": "http://interparfumsinc.com/role/ConsolidatedBalanceSheets", "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited)", "shortName": "CONSOLIDATED BALANCE SHEETS (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R3": { "role": "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)", "shortName": "CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R4": { "role": "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Unaudited)", "shortName": "CONSOLIDATED STATEMENTS OF INCOME (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "unique": true } }, "R5": { "role": "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome", "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "unique": true } }, "R6": { "role": "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited)", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R7": { "role": "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows", "longName": "00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "unique": true } }, "R8": { "role": "http://interparfumsinc.com/role/SignificantAccountingPolicies", "longName": "00000008 - Disclosure - Significant Accounting Policies:", "shortName": "Significant Accounting Policies:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R9": { "role": "http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic", "longName": "00000009 - Disclosure - Impact of COVID-19 Pandemic:", "shortName": "Impact of COVID-19 Pandemic:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R10": { "role": "http://interparfumsinc.com/role/RecentAgreements", "longName": "00000010 - Disclosure - Recent Agreements:", "shortName": "Recent Agreements:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R11": { "role": "http://interparfumsinc.com/role/RecentAccountingPronouncements", "longName": "00000011 - Disclosure - Recent Accounting Pronouncements:", "shortName": "Recent Accounting Pronouncements:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R12": { "role": "http://interparfumsinc.com/role/Inventories", "longName": "00000012 - Disclosure - Inventories:", "shortName": "Inventories:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R13": { "role": "http://interparfumsinc.com/role/FairValueMeasurement", "longName": "00000013 - Disclosure - Fair Value Measurement:", "shortName": "Fair Value Measurement:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R14": { "role": "http://interparfumsinc.com/role/DerivativeFinancialInstruments", "longName": "00000014 - Disclosure - Derivative Financial Instruments:", "shortName": "Derivative Financial Instruments:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R15": { "role": "http://interparfumsinc.com/role/Leases", "longName": "00000015 - Disclosure - Leases:", "shortName": "Leases:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R16": { "role": "http://interparfumsinc.com/role/Share-basedPayments", "longName": "00000016 - Disclosure - Share-Based Payments:", "shortName": "Share-Based Payments:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R17": { "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders", "longName": "00000017 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders:", "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R18": { "role": "http://interparfumsinc.com/role/SegmentAndGeographicAreas", "longName": "00000018 - Disclosure - Segment and Geographic Areas:", "shortName": "Segment and Geographic Areas:", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R19": { "role": "http://interparfumsinc.com/role/InventoriesTables", "longName": "00000019 - Disclosure - Inventories: (Tables)", "shortName": "Inventories: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R20": { "role": "http://interparfumsinc.com/role/FairValueMeasurementTables", "longName": "00000020 - Disclosure - Fair Value Measurement: (Tables)", "shortName": "Fair Value Measurement: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R21": { "role": "http://interparfumsinc.com/role/Share-basedPaymentsTables", "longName": "00000021 - Disclosure - Share-Based Payments: (Tables)", "shortName": "Share-Based Payments: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R22": { "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables", "longName": "00000022 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables)", "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R23": { "role": "http://interparfumsinc.com/role/SegmentAndGeographicAreasTables", "longName": "00000023 - Disclosure - Segment and Geographic Areas: (Tables)", "shortName": "Segment and Geographic Areas: (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R24": { "role": "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "longName": "00000024 - Disclosure - Recent Agreements: (Details Narrative)", "shortName": "Recent Agreements: (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PaymentsToAcquireProductiveAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PaymentsToAcquireProductiveAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R25": { "role": "http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails", "longName": "00000025 - Disclosure - Inventories consist of the following: (Details)", "shortName": "Inventories consist of the following: (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R26": { "role": "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails", "longName": "00000026 - Disclosure - The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details)", "shortName": "The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "AsOf2023-09-30_us-gaap_FairValueMeasurementsRecurringMember", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30_us-gaap_FairValueMeasurementsRecurringMember", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R27": { "role": "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "longName": "00000027 - Disclosure - Derivative Financial Instruments: (Details Narrative)", "shortName": "Derivative Financial Instruments: (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R28": { "role": "http://interparfumsinc.com/role/LeasesDetailsNarrative", "longName": "00000028 - Disclosure - Leases: (Details Narrative)", "shortName": "Leases: (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "unique": true } }, "R29": { "role": "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForNineMonthsEndedSeptember302023Details", "longName": "00000029 - Disclosure - The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023: (Details)", "shortName": "The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023: (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R30": { "role": "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfSeptember302023Details", "longName": "00000030 - Disclosure - The following table summarizes stock option information as of September 30, 2023: (Details)", "shortName": "The following table summarizes stock option information as of September 30, 2023: (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R31": { "role": "http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringNineMonthsEndedSeptember302023And2022WereAsFollowsDetails", "longName": "00000031 - Disclosure - Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows: (Details)", "shortName": "Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows: (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ProceedsFromSaleAndCollectionOfReceivables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ProceedsFromSaleAndCollectionOfReceivables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R32": { "role": "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative", "longName": "00000032 - Disclosure - Share-Based Payments: (Details Narrative)", "shortName": "Share-Based Payments: (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "From2022-07-012022-09-30", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "unique": true } }, "R33": { "role": "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails", "longName": "00000033 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)", "shortName": "The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "unique": true } }, "R34": { "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative", "longName": "00000034 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative)", "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true, "unique": true } }, "R35": { "role": "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails", "longName": "00000035 - Disclosure - Information on our operations by geographical areas is as follows: (Details)", "shortName": "Information on our operations by geographical areas is as follows: (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30_country_US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "g083828_10q.htm", "unique": true } } }, "tag": { "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_DividendsCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCash", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends", "label": "Dividends, Cash", "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred." } } }, "auth_ref": [ "r6", "r106" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current portion of long-term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r141" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current portion of lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r375" ] }, "us-gaap_StockRepurchasedDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedDuringPeriodValue", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares repurchased", "label": "Stock Repurchased During Period, Value", "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r14", "r75", "r76", "r106", "r433", "r491", "r512", "r566" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other assets", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r139" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r39" ] }, "us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsTables" ], "lang": { "en-us": { "role": { "label": "Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2023 and 2022 were as follows:", "documentation": "Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options." } } }, "auth_ref": [ "r18" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r302", "r303" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r168" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r168" ] }, "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Forward exchange contracts", "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r99", "r100", "r101" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Lease liabilities, less current portion", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r375" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $.001 par; authorized 100,000,000 shares; outstanding 31,980,805 and 31,967,300 shares at September 30, 2023 and December 31, 2022, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r76", "r402", "r553" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r76", "r452" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares, outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r14", "r76", "r452", "r470", "r641", "r642" ] }, "currency_AllCurrenciesDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "AllCurrenciesDomain", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long\u2013term debt, less current portion", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r142" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r341", "r347" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income attributable to Inter Parfums, Inc.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r32", "r154", "r156", "r163", "r396", "r414" ] }, "us-gaap_DistributionMadeToLimitedPartnerUnitDistribution": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DistributionMadeToLimitedPartnerUnitDistribution", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of share distributed", "documentation": "Number of units distributed for payment of a unit distribution to unit-holder of limited partnership (LP)." } } }, "auth_ref": [ "r106" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating lease, weighted average discount rate, percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r381", "r552" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "label": "Net income attributable to Inter Parfums, Inc. common shareholders:" } } }, "auth_ref": [] }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Transfer from OCI into earnings", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent." } } }, "auth_ref": [ "r19", "r31" ] }, "us-gaap_IncomeTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesReceivable", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Income taxes receivable", "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes." } } }, "auth_ref": [ "r74", "r589" ] }, "us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Change in fair value of derivatives", "documentation": "Amount of increase (decrease) in fair value from changes in the assumptions or model used to calculate the fair value of a contract to service financial assets under which the benefits of servicing are expected to more than adequately compensate the servicer." } } }, "auth_ref": [] }, "us-gaap_EscrowDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EscrowDeposit", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash held in escrow is included in other assets", "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy." } } }, "auth_ref": [ "r74", "r516" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Retained earnings", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r78", "r106", "r404", "r422", "r426", "r430", "r453", "r553" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive loss", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r30", "r31", "r85", "r143", "r403", "r423", "r426" ] }, "us-gaap_StockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockOptionMember", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Option [Member]", "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)." } } }, "auth_ref": [ "r557" ] }, "us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Transfer from other comprehensive income into earnings", "documentation": "Amount, after tax, of reclassification from other comprehensive income (loss) to earnings from the sale or complete or substantially complete liquidation of an investment in a foreign entity." } } }, "auth_ref": [ "r623" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" ], "lang": { "en-us": { "role": { "label": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders:", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r195", "r203", "r204", "r205" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Antidilutive potential common shares outstanding", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r203" ] }, "us-gaap_ProceedsFromSaleAndCollectionOfReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleAndCollectionOfReceivables", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringNineMonthsEndedSeptember302023And2022WereAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Cash proceeds from stock options exercised", "documentation": "The cash inflow associated with the proceeds from sale and collection of receivables during the period." } } }, "auth_ref": [ "r33" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r176", "r177", "r178", "r207", "r390", "r427", "r434", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r466", "r467", "r468", "r469", "r471", "r473", "r474", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r491", "r558" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Basic", "verboseLabel": "Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r164", "r185", "r186", "r187", "r188", "r189", "r196", "r198", "r200", "r201", "r202", "r206", "r336", "r337", "r397", "r415", "r534" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Receivables, other", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r582" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r571" ] }, "us-gaap_LongTermDebtTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtTerm", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Long-term debt, term", "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r621" ] }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of short-term investments", "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period." } } }, "auth_ref": [ "r33" ] }, "us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyFairValueHedgeLiabilityAtFairValue", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Foreign currency forward exchange contracts not accounted for using hedge accounting", "documentation": "Fair value as of the balance sheet date of all derivative liabilities designated as foreign currency fair value hedging instruments." } } }, "auth_ref": [ "r65" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfSeptember302023Details" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price options exercisable", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r287" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyFairValueHedgeAssetAtFairValue", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Foreign currency forward exchange contracts accounted for using hedge accounting", "documentation": "Fair value as of the balance sheet date of all derivative assets designated as foreign currency fair value hedging instruments." } } }, "auth_ref": [ "r65" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r14", "r132", "r157", "r158", "r159", "r176", "r177", "r178", "r182", "r190", "r192", "r207", "r240", "r243", "r274", "r298", "r299", "r300", "r305", "r306", "r325", "r326", "r327", "r328", "r329", "r331", "r335", "r362", "r363", "r364", "r365", "r366", "r368", "r382", "r419", "r420", "r421", "r433", "r491" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r1", "r13", "r31", "r326", "r329", "r382", "r419", "r420", "r593", "r594", "r595", "r599", "r600", "r601" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r176", "r177", "r178", "r207", "r390", "r427", "r434", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r466", "r467", "r468", "r469", "r471", "r473", "r474", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r491", "r558" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForNineMonthsEndedSeptember302023Details" ], "lang": { "en-us": { "role": { "label": "Nonvested options granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r288" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets", "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r116", "r140", "r174", "r212", "r222", "r227", "r239", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r316", "r320", "r349", "r400", "r464", "r553", "r567", "r607", "r608", "r627" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "label": "Income taxes", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r126", "r130", "r191", "r192", "r218", "r304", "r310", "r417" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r75", "r262" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciated over a range", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life of options outstanding (in years)", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r107" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life of options exercisable (in years)", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r50" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r75", "r452" ] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "(Gain) loss on foreign currency", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r353", "r355", "r357", "r359", "r488" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r166", "r169", "r170" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Other (income) expense", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r95" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r75", "r262" ] }, "us-gaap_InvestmentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Short-term investments", "label": "Investments, Fair Value Disclosure", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method." } } }, "auth_ref": [ "r342" ] }, "us-gaap_ExtraordinaryAndUnusualItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtraordinaryAndUnusualItemsAbstract", "lang": { "en-us": { "role": { "label": "Unusual or Infrequent Items, or Both [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r43", "r86" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity:", "verboseLabel": "Equity [Abstract]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Net derivative instrument (loss) gain, net of tax", "label": "Net derivative instrument gain (loss), net of tax", "documentation": "Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method." } } }, "auth_ref": [ "r149", "r150", "r151", "r322" ] }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" ], "lang": { "en-us": { "role": { "label": "The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r602" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockSplits", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Adjusted for stock splits", "documentation": "Number of shares issued during the period as a result of a stock split." } } }, "auth_ref": [ "r14", "r75", "r76", "r106" ] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating lease liabilities", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r588", "r596" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "label": "Earnings per share:", "verboseLabel": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfSeptember302023Details" ], "lang": { "en-us": { "role": { "negatedLabel": "Options exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r14", "r75", "r76", "r106", "r289" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r581" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedTaxesPayable", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income taxes, net", "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes." } } }, "auth_ref": [ "r596" ] }, "us-gaap_AcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquisitionCosts", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Acquisition costs, period cost", "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties." } } }, "auth_ref": [ "r114", "r115" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://interparfumsinc.com/role/FairValueMeasurementTables" ], "lang": { "en-us": { "role": { "label": "The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r342", "r343" ] }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income to net cash provided by (used in) operating activities:" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://interparfumsinc.com/role/InventoriesTables" ], "lang": { "en-us": { "role": { "label": "Inventories consist of the following:", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r21", "r82", "r83", "r84" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r342", "r343", "r346" ] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Assets:" } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsTables" ], "lang": { "en-us": { "role": { "label": "The following table summarizes stock option information as of September 30, 2023:", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r16", "r17", "r51" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r9", "r216" ] }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsTables" ], "lang": { "en-us": { "role": { "label": "The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2023:", "documentation": "Tabular disclosure of the changes in outstanding nonvested shares." } } }, "auth_ref": [ "r52" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r260", "r278", "r279", "r280", "r281", "r282", "r283", "r385", "r386", "r387", "r537", "r538", "r541", "r542", "r543" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r583" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Noncash additions to operating lease assets", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r377", "r552" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://interparfumsinc.com/role/Leases" ], "lang": { "en-us": { "role": { "label": "Leases:", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r373" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r246", "r247", "r248", "r249", "r277", "r284", "r293", "r294", "r295", "r388", "r389", "r418", "r444", "r445", "r496", "r498", "r500", "r501", "r510", "r527", "r528", "r536", "r539", "r546", "r554", "r557", "r605", "r611", "r630", "r631", "r632", "r633", "r634" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r38", "r138", "r531" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "totalLabel": "Income before income taxes", "label": "Income before income taxes", "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments." } } }, "auth_ref": [ "r212", "r221", "r226", "r229", "r416", "r535" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r246", "r247", "r248", "r249", "r284", "r389", "r418", "r444", "r445", "r496", "r498", "r500", "r501", "r510", "r527", "r528", "r536", "r539", "r546", "r554", "r611", "r629", "r630", "r631", "r632", "r633", "r634" ] }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "presentation": [ "http://interparfumsinc.com/role/RecentAccountingPronouncements" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements:", "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle." } } }, "auth_ref": [ "r128", "r129", "r131", "r134", "r179", "r180", "r183", "r184", "r193", "r194", "r241", "r242", "r307", "r308", "r309", "r330", "r334", "r338", "r339", "r340", "r350", "r351", "r352", "r371", "r372", "r383", "r391", "r392", "r393", "r422", "r423", "r424", "r425", "r426" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "auth_ref": [ "r246", "r247", "r248", "r249", "r277", "r284", "r293", "r294", "r295", "r388", "r389", "r418", "r444", "r445", "r496", "r498", "r500", "r501", "r510", "r527", "r528", "r536", "r539", "r546", "r554", "r557", "r605", "r611", "r630", "r631", "r632", "r633", "r634" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in:" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r246", "r247", "r248", "r249", "r284", "r389", "r418", "r444", "r445", "r496", "r498", "r500", "r501", "r510", "r527", "r528", "r536", "r539", "r546", "r554", "r611", "r629", "r630", "r631", "r632", "r633", "r634" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r580" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r236", "r237" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "label": "Dividends declared per share", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r106" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_BuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingMember", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Building [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r104" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r572" ] }, "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of recent agreement", "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information." } } }, "auth_ref": [ "r56" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r573" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r342", "r343", "r346" ] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://interparfumsinc.com/role/Inventories" ], "lang": { "en-us": { "role": { "label": "Inventories:", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r245" ] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeContractMember", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r533", "r541", "r551" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r577" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Noncontrolling interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r29", "r118", "r174", "r239", "r250", "r252", "r253", "r254", "r257", "r258", "r349", "r405", "r454" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Deferred tax benefit", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r9", "r108", "r127", "r311", "r312", "r598" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized compensation cost", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r297" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r555", "r556", "r557", "r559", "r560", "r561", "r564", "r599", "r600", "r620", "r637", "r641" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable \u2013 trade", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r22", "r553" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForNineMonthsEndedSeptember302023Details" ], "lang": { "en-us": { "role": { "periodStartLabel": "Nonvested options beginning of period", "periodEndLabel": "Nonvested options end of period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "documentation": "Number of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r55", "r57", "r313", "r544", "r545" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForNineMonthsEndedSeptember302023Details" ], "lang": { "en-us": { "role": { "negatedLabel": "Nonvested options vested or forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "documentation": "Number of non-vested options forfeited." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Translation adjustments, net of tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r2" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r313", "r544", "r545" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForNineMonthsEndedSeptember302023Details" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average grant date fair value, beginning of year", "periodEndLabel": "Weighted average grant date fair value, nonvested options end of period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "documentation": "Weighted average grant-date fair value of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net income attributable to Inter Parfums, Inc. common shareholders:" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForNineMonthsEndedSeptember302023Details" ], "lang": { "en-us": { "role": { "label": "Weighted average grant date fair value, nonvested options vested or forfeited", "documentation": "Weighted average grant-date fair value of non-vested options forfeited." } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "label": "Cost of sales", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r90", "r390" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r55", "r57", "r313" ] }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingChangesAndErrorCorrectionsAbstract", "lang": { "en-us": { "role": { "label": "Accounting Changes and Error Corrections [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r313" ] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Purchase of subsidiary shares", "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders." } } }, "auth_ref": [ "r11", "r47", "r111" ] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership percentage", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate shares to offices and managers", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r548" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfSeptember302023Details" ], "lang": { "en-us": { "role": { "label": "Options available for future grants", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r50" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringNineMonthsEndedSeptember302023And2022WereAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Intrinsic value of stock options exercised", "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares." } } }, "auth_ref": [ "r292" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of shares vested", "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock." } } }, "auth_ref": [ "r292" ] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of long-term debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r34", "r428" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfSeptember302023Details" ], "lang": { "en-us": { "role": { "negatedLabel": "Options forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r290" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Options granted", "documentation": "Net number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r614" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r136", "r146", "r174", "r239", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r316", "r320", "r349", "r553", "r607", "r608", "r627" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income attributable to Inter Parfums, Inc.", "label": "Net income attributable to Inter Parfums, Inc.", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r88", "r101", "r123", "r135", "r152", "r155", "r159", "r174", "r181", "r185", "r186", "r187", "r188", "r191", "r192", "r199", "r212", "r221", "r226", "r229", "r239", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r337", "r349", "r411", "r472", "r489", "r490", "r535", "r565", "r607" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForNineMonthsEndedSeptember302023Details" ], "lang": { "en-us": { "role": { "label": "Weighted average grant date fair value, nonvested options granted", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r291" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate intrinsic value of options outstanding and options outstanding", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r50" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r64", "r65", "r66", "r67", "r443", "r445", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r466", "r467", "r468", "r478", "r479", "r480", "r481", "r484", "r485", "r486", "r487", "r503", "r504", "r506", "r508", "r533", "r555", "r557" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfSeptember302023Details" ], "lang": { "en-us": { "role": { "label": "Options exercisable", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r287" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfSeptember302023Details" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price shares under option - beginning of year", "periodEndLabel": "Weighted average exercise price shares under option - end of year", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r285", "r286" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r104" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfSeptember302023Details" ], "lang": { "en-us": { "role": { "periodStartLabel": "Options shares under option - beginning of year", "periodEndLabel": "Options shares under option - end of year", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r285", "r286" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r570" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Inter Parfums, Inc. shareholders\u2019 equity:" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r578" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Gross margin", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r89", "r174", "r212", "r221", "r226", "r229", "r239", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r349", "r535", "r607" ] }, "us-gaap_PaymentsToAcquireInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireInvestments", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of short-term investments", "label": "Payments to Acquire Investments", "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period." } } }, "auth_ref": [ "r97" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r570" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate intrinsic value of options outstanding and options exercisable", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r50" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of long-term debt", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r37", "r429" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r570" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://interparfumsinc.com/role/Share-basedPayments" ], "lang": { "en-us": { "role": { "label": "Share-Based Payments:", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r105", "r173", "r261", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r333", "r494", "r495", "r514" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r586" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r570" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Share-based compensation", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r53", "r75", "r76", "r106" ] }, "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualOrInfrequentItemsDisclosureTextBlock", "presentation": [ "http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" ], "lang": { "en-us": { "role": { "label": "Impact of COVID-19 Pandemic:", "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both." } } }, "auth_ref": [ "r96" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r587" ] }, "srt_CurrencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CurrencyAxis", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Currency [Axis]" } } }, "auth_ref": [ "r624" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income:" } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "us-gaap_PaymentsToMinorityShareholders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToMinorityShareholders", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of subsidiary shares from noncontrolling interest", "label": "Payments to Noncontrolling Interests", "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest." } } }, "auth_ref": [ "r35" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r581" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of property, equipment and leasehold improvements", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r98" ] }, "us-gaap_DeferredTaxExpenseFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxExpenseFromStockOptionsExercised", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringNineMonthsEndedSeptember302023And2022WereAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Tax benefits", "documentation": "Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued expenses", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r8" ] }, "us-gaap_TaxesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxesPayableCurrent", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Income taxes payable", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r23" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r8" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued upon exercise of stock options", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r14", "r28", "r106" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r8" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r576" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other current assets", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r145", "r553" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "label": "Other expenses (income):" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromBankDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromBankDebt", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from loans payable, bank", "documentation": "The cash inflow from bank borrowing during the year." } } }, "auth_ref": [ "r34" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r260", "r278", "r279", "r280", "r281", "r282", "r283", "r343", "r385", "r386", "r387", "r537", "r538", "r541", "r542", "r543" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r575" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r574" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Nonoperating expense (income)", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r93" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock, $.001 par; authorized 1,000,000 shares; none issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r75", "r401", "r553" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Total asset", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r70" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r342", "r343", "r344", "r345", "r347" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r582" ] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Total liabilities", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r70" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r76" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r77", "r553", "r639" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation adjustment, net of tax", "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r2", "r4", "r354", "r358", "r367" ] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://interparfumsinc.com/role/SegmentAndGeographicAreas" ], "lang": { "en-us": { "role": { "label": "Segment and Geographic Areas:", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r208", "r209", "r210", "r211", "r212", "r219", "r223", "r227", "r228", "r229", "r230", "r231", "r232", "r235" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r25", "r137", "r174", "r239", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r317", "r320", "r321", "r349", "r553", "r607", "r627", "r628" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Translation adjustments, net of tax", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3", "r85", "r354", "r356", "r361" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r603", "r626" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateTerms": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateTerms", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of debt instrument interest rate terms", "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets." } } }, "auth_ref": [ "r26" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "auth_ref": [] }, "us-gaap_LoansPayableToBank": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansPayableToBank", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Loans payable - banks", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the normal operating cycle if longer." } } }, "auth_ref": [ "r20", "r117", "r635" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Income from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r212", "r221", "r226", "r229", "r535" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://interparfumsinc.com/role/SegmentAndGeographicAreasTables" ], "lang": { "en-us": { "role": { "label": "Information on our operations by geographical areas is as follows:", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r40", "r41", "r42", "r44" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities:" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r10" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r63", "r110", "r154", "r156", "r161", "r394", "r412" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r81", "r119", "r406", "r553", "r597", "r604", "r622" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Property, equipment and leasehold improvements, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r10", "r399", "r407", "r553" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND EQUITY" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireProductiveAssets", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase price, period cost", "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r125", "r615", "r616", "r617" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income attributable to the noncontrolling interests", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r7", "r60", "r63", "r154", "r156", "r162", "r395", "r413" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expenses", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r91" ] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EuropeMember", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Europe [Member]" } } }, "auth_ref": [ "r643", "r644", "r645", "r646" ] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Provision for doubtful accounts", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r165", "r244" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Net derivative instrument (loss) gain, net of tax", "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests." } } }, "auth_ref": [ "r7", "r12", "r110", "r153", "r156" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfSeptember302023Details" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price options exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r289" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfSeptember302023Details" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price options forfeited", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r290" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets", "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity", "periodStartLabel": "Beginning Balance", "periodEndLabel": "Ending Balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r58", "r59", "r61", "r132", "r133", "r158", "r176", "r177", "r178", "r182", "r190", "r240", "r243", "r274", "r298", "r299", "r300", "r305", "r306", "r325", "r326", "r327", "r328", "r329", "r331", "r335", "r362", "r363", "r368", "r382", "r420", "r421", "r431", "r454", "r470", "r492", "r493", "r513", "r566", "r597", "r604", "r622", "r641" ] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment for intangible assets acquired", "label": "Payments to Acquire Intangible Assets", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r98" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r298", "r299", "r300", "r433", "r599", "r600", "r601", "r620", "r641" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r58", "r274", "r599", "r600", "r601", "r641" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://interparfumsinc.com/role/RecentAgreements" ], "lang": { "en-us": { "role": { "label": "Recent Agreements:", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r109", "r314" ] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Long-term line of credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r20", "r117", "r635" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Inter Parfums, Inc. shareholders\u2019 equity", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r76", "r79", "r80", "r103", "r454", "r470", "r492", "r493", "r553", "r567", "r597", "r604", "r622", "r641" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "auth_ref": [ "r233", "r234", "r437", "r440", "r442", "r497", "r499", "r502", "r511", "r515", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r530", "r540", "r557", "r612", "r636" ] }, "us-gaap_TreasuryStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValue", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock, at cost, 9,949,865 and 9,864,805 shares at September 30, 2023 and December 31, 2022, respectively", "label": "Treasury Stock, Value", "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury." } } }, "auth_ref": [ "r27", "r48", "r49" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued expenses", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r24" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r443", "r445", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r466", "r467", "r468", "r478", "r479", "r480", "r481", "r484", "r485", "r486", "r487", "r503", "r504", "r506", "r508", "r555", "r557" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r579", "r581", "r582" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Diluted", "verboseLabel": "Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r164", "r185", "r186", "r187", "r188", "r189", "r198", "r200", "r201", "r202", "r206", "r336", "r337", "r397", "r415", "r534" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Noncash lease expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r625" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-based payment arrangement, expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r296", "r301" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstruments" ], "lang": { "en-us": { "role": { "label": "Derivative Financial Instruments:", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r113", "r324", "r332" ] }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossLineItems", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments, Gain (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r323" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income attributable to the noncontrolling interests:" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments, Gain (Loss) [Table]", "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r15", "r64", "r66", "r67", "r68", "r69", "r323" ] }, "us-gaap_DerivativeSwaptionInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeSwaptionInterestRate", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Derivative swap interest rate", "documentation": "Fixed interest rate that will be received or paid upon exercise of the interest rate swaption contract." } } }, "auth_ref": [] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r618", "r619" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Share of income of equity investment", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r9", "r87", "r122", "r217", "r238", "r408" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Noncash stock compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r8" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r48" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating lease, payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r376", "r378" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Treasury stock, shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r48" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "auth_ref": [ "r233", "r234", "r437", "r440", "r442", "r497", "r499", "r502", "r511", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r530", "r540", "r557", "r612", "r636" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instrument, face amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r71", "r73", "r259", "r370", "r537", "r538" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "auth_ref": [ "r175", "r316", "r317", "r320", "r321", "r384", "r526", "r606", "r609", "r610" ] }, "us-gaap_PaymentsForRepurchaseOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfEquity", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of treasury stock", "label": "Payments for Repurchase of Equity", "documentation": "The cash outflow to reacquire common and preferred stock." } } }, "auth_ref": [ "r36", "r429" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "label": "Interest expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r72", "r124", "r160", "r215", "r369", "r475", "r565", "r640" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r175", "r316", "r317", "r320", "r321", "r384", "r526", "r606", "r609", "r610" ] }, "us-gaap_InvestmentIncomeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeNet", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest and investment income", "label": "Investment Income, Net", "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities." } } }, "auth_ref": [ "r92", "r94" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDividendsMinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsMinorityInterest", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends paid to noncontrolling interest", "label": "Payments of Ordinary Dividends, Noncontrolling Interest", "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests." } } }, "auth_ref": [ "r36" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r568" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_DerivativeVariableInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeVariableInterestRate", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Variable interest rate", "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOwnershipPlanESOPCompensationExpense", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Recognized as compensation cost", "documentation": "The amount of plan compensation cost recognized during the period." } } }, "auth_ref": [ "r54" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Trademarks, licenses and other intangible assets, net", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r45", "r46" ] }, "us-gaap_PaymentsOfDividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsCommonStock", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends paid", "label": "Payments of Ordinary Dividends, Common Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity." } } }, "auth_ref": [ "r36" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income:" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r260", "r278", "r283", "r343", "r386", "r537", "r538", "r541", "r542", "r543" ] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r581" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r260", "r278", "r283", "r343", "r385", "r541", "r542", "r543" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Interest rate swaps", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r147", "r148", "r348", "r435", "r436", "r437", "r438", "r439", "r441", "r442", "r443", "r444", "r445", "r458", "r459", "r503", "r505", "r506", "r507", "r508", "r509", "r533", "r557", "r638" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r14", "r28", "r132", "r157", "r158", "r159", "r176", "r177", "r178", "r182", "r190", "r192", "r207", "r240", "r243", "r274", "r298", "r299", "r300", "r305", "r306", "r325", "r326", "r327", "r328", "r329", "r331", "r335", "r362", "r363", "r364", "r365", "r366", "r368", "r382", "r419", "r420", "r421", "r433", "r491" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r260", "r278", "r279", "r280", "r281", "r282", "r283", "r343", "r387", "r537", "r538", "r541", "r542", "r543" ] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating leases, rent expense, net", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r379", "r552" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r584" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r569" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r132", "r176", "r177", "r178", "r182", "r190", "r192", "r240", "r243", "r298", "r299", "r300", "r305", "r306", "r325", "r327", "r328", "r331", "r335", "r419", "r421", "r433", "r641" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows", "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome", "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "label": "Net income", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r135", "r152", "r155", "r167", "r174", "r181", "r191", "r192", "r212", "r221", "r226", "r229", "r239", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r315", "r318", "r319", "r337", "r349", "r398", "r409", "r432", "r472", "r489", "r490", "r535", "r549", "r550", "r566", "r595", "r607" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r570" ] }, "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiaryOrEquityMethodInvesteeLineItems", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsidiary or Equity Method Investee [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ipar_RobertoCavalliMember": { "xbrltype": "domainItemType", "nsuri": "http://interparfumsinc.com/20230930", "localname": "RobertoCavalliMember", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Roberto Cavalli [Member]", "documentation": "The element represents roberto cavalli member." } } }, "auth_ref": [] }, "us-gaap_LandMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LandMember", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Land [Member]", "documentation": "Part of earth's surface not covered by water." } } }, "auth_ref": [ "r613" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r570" ] }, "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Subsidiary or Equity Method Investee [Table]", "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome", "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "label": "Less:\u00a0\u00a0Net income attributable to the noncontrolling interest", "verboseLabel": "Net income", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r62", "r112", "r152", "r155", "r191", "r192", "r410", "r595" ] }, "ipar_DonnaKaranAndDKNYMember": { "xbrltype": "domainItemType", "nsuri": "http://interparfumsinc.com/20230930", "localname": "DonnaKaranAndDKNYMember", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Donna Karan and DKNY [Member]", "documentation": "The element represents donna karan and dkny member." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding:", "verboseLabel": "Denominator:" } } }, "auth_ref": [] }, "ipar_LacosteMember": { "xbrltype": "domainItemType", "nsuri": "http://interparfumsinc.com/20230930", "localname": "LacosteMember", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lacoste [Member]", "documentation": "The element represents lacoste member." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r582" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets", "label": "Increase (Decrease) in Other Operating Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r8" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets", "http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails" ], "lang": { "en-us": { "role": { "label": "Inventories", "totalLabel": "Inventories", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r144", "r532", "r553" ] }, "us-gaap_InterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateSwapMember", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest Rate Swap [Member]", "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period." } } }, "auth_ref": [ "r529", "r562", "r563" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets, net", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r374" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r570" ] }, "ipar_RochasFashionMember": { "xbrltype": "domainItemType", "nsuri": "http://interparfumsinc.com/20230930", "localname": "RochasFashionMember", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Rochas Fashion [Member]", "documentation": "The element represents rochas fashion member." } } }, "auth_ref": [] }, "us-gaap_InventoryRawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterials", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails" ], "lang": { "en-us": { "role": { "label": "Raw materials and component parts", "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r591" ] }, "us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaximumRemainingMaturityOfForeignCurrencyDerivatives1", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maturity of foreign currency", "documentation": "Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "ipar_InterparfumsSAMember": { "xbrltype": "domainItemType", "nsuri": "http://interparfumsinc.com/20230930", "localname": "InterparfumsSAMember", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interparfums SA [Member]", "documentation": "The element represents interparfums s a member." } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for:" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "us-gaap_ShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermInvestments", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Short-term investments", "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current." } } }, "auth_ref": [ "r120", "r121", "r592" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ipar_InterparfumsSASubsidiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://interparfumsinc.com/20230930", "localname": "InterparfumsSASubsidiaryMember", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interparfums SA Subsidiary [Member]", "documentation": "The element represents interparfums s a subsidiary member." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Options vesting period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r547" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from exercise of options", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r5", "r18" ] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://interparfumsinc.com/role/FairValueMeasurement" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement:", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r341" ] }, "ipar_OfficersAndManagersMember": { "xbrltype": "domainItemType", "nsuri": "http://interparfumsinc.com/20230930", "localname": "OfficersAndManagersMember", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Officers and Managers [Member]", "documentation": "The element represents officers and managers member." } } }, "auth_ref": [] }, "currency_EUR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "EUR", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Euro Member Countries, Euro" } } }, "auth_ref": [] }, "ipar_EmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://interparfumsinc.com/20230930", "localname": "EmployeesMember", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employees [Member]", "documentation": "The element represents employees member." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Numerator:" } } }, "auth_ref": [] }, "us-gaap_DerivativeFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFixedInterestRate", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fixed interest rate", "documentation": "Fixed interest rate related to the interest rate derivative." } } }, "auth_ref": [] }, "currency_GBP": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "GBP", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "United Kingdom, Pounds" } } }, "auth_ref": [] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoods", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails" ], "lang": { "en-us": { "role": { "label": "Finished goods", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r590" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of exchange rate changes on cash", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r360" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://interparfumsinc.com/role/SignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies:", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r102", "r172" ] }, "ipar_EliminationsMember": { "xbrltype": "domainItemType", "nsuri": "http://interparfumsinc.com/20230930", "localname": "EliminationsMember", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Eliminations [Member]", "documentation": "The element represents eliminations member." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net decrease in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r99" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r585" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating lease, weighted average remaining lease term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r380", "r552" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents - beginning of period", "periodEndLabel": "Cash and cash equivalents - end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r38", "r99", "r171" ] }, "ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://interparfumsinc.com/20230930", "localname": "TransferOfSubsidiarySharesPurchasedToTreasuryShares", "crdr": "credit", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Purchase of subsidiary shares", "documentation": "The element represents transfer of subsidiary shares purchased to treasury shares.", "label": "Transfer of Subsidiary Shares Purchased to Treasury Shares" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "lang": { "en-us": { "role": { "verboseLabel": "Diluted", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r197", "r202" ] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "calculation": { "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails": { "parentTag": "us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Stock options", "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation." } } }, "auth_ref": [ "r602" ] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Net sales", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r213", "r214", "r220", "r224", "r225", "r231", "r233", "r235", "r275", "r276", "r390" ] }, "us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProFormaWeightedAverageSharesOutstandingDiluted", "calculation": { "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "label": "Denominator for diluted earnings per share", "documentation": "The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r581" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails": { "parentTag": "us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Basic", "label": "Weighted average shares", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r196", "r202" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a-c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29,30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "40", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480489/718-40-50-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//220-20/tableOfContent" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "932", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479664/932-10-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "932", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-10(c)(7)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479664/932-10-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//250/tableOfContent" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(dd)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-6" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r530": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r531": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r534": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r535": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r536": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r537": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r538": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r539": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r540": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r541": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r544": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r545": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r546": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r547": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r548": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r550": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r551": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r552": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r553": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r554": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r555": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r557": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r562": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r563": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r564": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r565": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r566": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r567": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r568": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r569": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r570": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r572": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r574": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r575": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r576": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r577": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r578": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r579": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r580": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r581": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r582": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r583": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r585": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r586": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r587": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r588": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r589": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r590": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r591": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r592": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r593": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r594": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r595": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r596": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r597": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r598": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r599": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r600": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r601": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r602": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r603": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r604": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r605": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r606": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r607": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r608": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r609": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r610": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r611": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r612": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r613": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r614": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r615": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1" }, "r616": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1" }, "r617": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2" }, "r618": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1" }, "r625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 54 0001753926-23-001432-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001753926-23-001432-xbrl.zip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�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end